<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1123" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1123/" /><meta name="ncbi_pagename" content="Multiple Epiphyseal Dysplasia, Autosomal Dominant - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Multiple Epiphyseal Dysplasia, Autosomal Dominant - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Multiple Epiphyseal Dysplasia, Autosomal Dominant" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/04/25" /><meta name="citation_author" content="Michael D Briggs" /><meta name="citation_author" content="Michael J Wright" /><meta name="citation_author" content="Geert R Mortier" /><meta name="citation_pmid" content="20301302" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1123/" /><meta name="citation_keywords" content="Cartilage oligomeric matrix protein" /><meta name="citation_keywords" content="Collagen alpha-1(IX) chain" /><meta name="citation_keywords" content="Collagen alpha-2(IX) chain" /><meta name="citation_keywords" content="Collagen alpha-3(IX) chain" /><meta name="citation_keywords" content="Matrilin-3" /><meta name="citation_keywords" content="COL9A1" /><meta name="citation_keywords" content="COL9A2" /><meta name="citation_keywords" content="COL9A3" /><meta name="citation_keywords" content="COMP" /><meta name="citation_keywords" content="MATN3" /><meta name="citation_keywords" content="Multiple Epiphyseal Dysplasia, Autosomal Dominant" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Multiple Epiphyseal Dysplasia, Autosomal Dominant" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Michael D Briggs" /><meta name="DC.Contributor" content="Michael J Wright" /><meta name="DC.Contributor" content="Geert R Mortier" /><meta name="DC.Date" content="2019/04/25" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1123/" /><meta name="description" content="Autosomal dominant multiple epiphyseal dysplasia (MED) presents in early childhood, usually with pain in the hips and/or knees after exercise. Affected children complain of fatigue with long-distance walking. Waddling gait may be present. Adult height is either in the lower range of normal or mildly shortened. The limbs are relatively short in comparison to the trunk. Pain and joint deformity progress, resulting in early-onset osteoarthritis, particularly of the large weight-bearing joints." /><meta name="og:title" content="Multiple Epiphyseal Dysplasia, Autosomal Dominant" /><meta name="og:type" content="book" /><meta name="og:description" content="Autosomal dominant multiple epiphyseal dysplasia (MED) presents in early childhood, usually with pain in the hips and/or knees after exercise. Affected children complain of fatigue with long-distance walking. Waddling gait may be present. Adult height is either in the lower range of normal or mildly shortened. The limbs are relatively short in comparison to the trunk. Pain and joint deformity progress, resulting in early-onset osteoarthritis, particularly of the large weight-bearing joints." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1123/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/edm-ad/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1123/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE884520DFC83B3100000000072C035D.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1123_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1123_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/men2/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/edm/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1123_"><span class="title" itemprop="name">Multiple Epiphyseal Dysplasia, Autosomal Dominant</span></h1><p class="contrib-group"><span itemprop="author">Michael D Briggs</span>, PhD, <span itemprop="author">Michael J Wright</span>, MB, ChB, MSc, FRCP, and <span itemprop="author">Geert R Mortier</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1123_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1123_ai__"><div class="contrib half_rhythm"><span itemprop="author">Michael D Briggs</span>, PhD<div class="affiliation small">Professor of Skeletal Genetics, Institute of Genetic Medicine<br />Newcastle University<br />International Centre for Life<br />Newcastle upon Tyne, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.eltsacwen@sggirb.leahcim" class="oemail">ku.ca.eltsacwen@sggirb.leahcim</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Michael J Wright</span>, MB, ChB, MSc, FRCP<div class="affiliation small">Consultant Clinical Geneticist, Northern Genetics Service<br />Institute of Human Genetics<br />Newcastle upon Tyne, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.shn.htun@thgirw.leahcim" class="oemail">ku.shn.htun@thgirw.leahcim</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Geert R Mortier</span>, MD, PhD<div class="affiliation small">Chairman, Department of Medical Genetics<br />Antwerp University Hospital<br />Antwerp, Belgium<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="eb.ca.au@reitrom.treeg" class="oemail">eb.ca.au@reitrom.treeg</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">January 8, 2003</span>; Last Update: <span itemprop="dateModified">April 25, 2019</span>.</p><p><em>Estimated reading time: 27 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="edm-ad.Summary" itemprop="description"><h2 id="_edm-ad_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Autosomal dominant multiple epiphyseal dysplasia (MED) presents in early childhood, usually with pain in the hips and/or knees after exercise. Affected children complain of fatigue with long-distance walking. Waddling gait may be present. Adult height is either in the lower range of normal or mildly shortened. The limbs are relatively short in comparison to the trunk. Pain and joint deformity progress, resulting in early-onset osteoarthritis, particularly of the large weight-bearing joints.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> MED is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the typical clinical and radiographic findings and/or a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>COL9A1</i>, <i>COL9A2</i>, <i>COL9A3</i>, <i>COMP</i>, or <i>MATN3</i> identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> For pain control, a combination of analgesics and physiotherapy including hydrotherapy; referral to a rheumatologist or pain specialist as needed; consideration of realignment osteotomy and/or acetabular osteotomy to limit joint destruction and development of osteoarthritis. Consider total joint arthroplasty if the degenerative hip changes cause uncontrollable pain/dysfunction; offer psychosocial support addressing issues of short stature, chronic pain, disability, and employment.</p><p><i>Surveillance:</i> Evaluation by an orthopedic surgeon for chronic pain and/or limb deformities (genu varum, genu valgum).</p><p><i>Agents/circumstances to avoid:</i> Obesity; exercise causing repetitive strain on affected joints.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Many individuals with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> MED have inherited the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from a parent. The prevalence of <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variants is not known. Each child of an individual with autosomal dominant MED has a 50% chance of inheriting the pathogenic variant. Prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for autosomal dominant multiple epiphyseal dysplasia are possible if the pathogenic variant has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member.</p></div></div><div id="edm-ad.Diagnosis"><h2 id="_edm-ad_Diagnosis_">Diagnosis</h2><div id="edm-ad.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Autosomal dominant multiple epiphyseal dysplasia (MED) <b>should be suspected</b> in individuals with the following clinical and radiographic findings.</p><p><b>Clinical findings</b></p><ul><li class="half_rhythm"><div>Pain in the hips and/or knees and fatigue, often after exercise (frequently starting in early childhood)</div></li><li class="half_rhythm"><div>Adult height in the lower range of normal or mildly shortened</div></li><li class="half_rhythm"><div>Restricted range of movement at the major joints (e.g., elbows)</div></li><li class="half_rhythm"><div>Early-onset osteoarthritis, often requiring joint replacement in the second or third decade of life</div></li></ul><p><b>Radiographic findings</b></p><ul><li class="half_rhythm"><div>Initially, often before the onset of clinical symptoms, delayed ossification of the epiphyses of the long tubular bones is observed. When the epiphyses appear, the ossification centers are small with irregular contours. Epiphyseal abnormalities are usually most pronounced in the knees and/or hips, where they may resemble bilateral Perthes disease (see <a href="#edm-ad.Differential_Diagnosis">Differential Diagnosis</a>).</div></li><li class="half_rhythm"><div>In childhood, the tubular bones may be mildly shortened. Ivory (very dense) epiphyses may be present in the hands. By definition, the spine is normal; however, Schmorl bodies (i.e., the displacement of intervertebral disk tissue into the vertebral bodies) and irregular vertebral end plates can be observed.</div></li><li class="half_rhythm"><div>In adulthood, signs of osteoarthritis are usually observed. It is often impossible to make a diagnosis of MED on adult x-rays alone.</div></li></ul></div><div id="edm-ad.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> MED <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the above clinical and radiographic findings and/or a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in a MED-related <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> (see <a class="figpopup" href="/books/NBK1123/table/edm-ad.T.molecular_genetic_testing_used/?report=objectonly" target="object" rid-figpopup="figedmadTmoleculargenetictestingused" rid-ob="figobedmadTmoleculargenetictestingused">Table 1</a>) identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> MED is broad, individuals with the distinctive findings described in <a href="#edm-ad.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#edm-ad.Option_1">Option 1</a>), whereas those with atypical clinical findings in whom the diagnosis of autosomal dominant MED has not been considered are more likely to be diagnosed using genomic testing (see <a href="#edm-ad.Option_2">Option 2</a>).</p><div id="edm-ad.Option_1"><h4>Option 1</h4><p>When the phenotypic and radiographic findings suggest the diagnosis of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> MED, the recommended <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approach is to use a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>.</p><p><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>COL9A1</i>, <i>COL9A2</i>, <i>COL9A3</i>, <i>COMP</i>, <i>MATN3</i>, and other genes of interest (see <a href="#edm-ad.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p></div><div id="edm-ad.Option_2"><h4>Option 2</h4><p>When the diagnosis of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> MED is not considered because an individual has atypical phenotypic features, <b>comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option. <b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="edm-ad.T.molecular_genetic_testing_used" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Autosomal Dominant Multiple Epiphyseal Dysplasia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1123/table/edm-ad.T.molecular_genetic_testing_used/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__edm-ad.T.molecular_genetic_testing_used_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1,&#x000a0;2</sup></th><th id="hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_1_2" style="text-align:left;vertical-align:middle;">Proportion of Autosomal Dominant MED Attributed to Pathogenic Variants in This Gene&#x000a0;<sup>3,&#x000a0;4</sup></th><th id="hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>5</sup> Detectable by Method</th></tr><tr><th headers="hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_1_3" id="hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>6</sup></th><th headers="hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_1_3" id="hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>7</sup></th></tr></thead><tbody><tr><td headers="hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COL9A1</i></td><td headers="hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_1_2" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;">10%</td><td headers="hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_1_3 hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%&#x000a0;<sup>8</sup></td><td headers="hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_1_3 hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported&#x000a0;<sup>9</sup></td></tr><tr><td headers="hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COL9A2</i></td><td headers="hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_1_3 hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_2_1" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">100%&#x000a0;<sup>8</sup></td><td headers="hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_1_3 hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported&#x000a0;<sup>9</sup></td></tr><tr><td headers="hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COL9A3</i></td><td headers="hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_1_3 hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_2_1" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">100%&#x000a0;<sup>8</sup></td><td headers="hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_1_3 hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported&#x000a0;<sup>9</sup></td></tr><tr><td headers="hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COMP</i></td><td headers="hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">50%</td><td headers="hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_1_3 hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%&#x000a0;<sup>8</sup></td><td headers="hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_1_3 hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported&#x000a0;<sup>9</sup></td></tr><tr><td headers="hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MATN3</i></td><td headers="hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">20%</td><td headers="hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_1_3 hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%&#x000a0;<sup>8</sup></td><td headers="hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_1_3 hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>10</sup></td></tr><tr><td headers="hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>11</sup></td><td headers="hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~20%?</td><td headers="hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_1_3 hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_2_1 hd_h_edm-ad.T.molecular_genetic_testing_used_1_1_2_2" colspan="2" rowspan="1" style="text-align:left;vertical-align:middle;">NA</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="edm-ad.TF.1.1"><p class="no_margin">Genes are listed in alphabetic order.</p></div></dd><dt>2. </dt><dd><div id="edm-ad.TF.1.2"><p class="no_margin">See <a href="/books/NBK1123/#edm-ad.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>3. </dt><dd><div id="edm-ad.TF.1.3"><p class="no_margin">In individuals with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> MED in whom a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in one of the five confirmed genes has been identified. However, the relative proportions are different depending on ethnicity. For example, a recent study by the European Skeletal Dysplasia Network (ESDN) [<a class="bk_pop" href="#edm-ad.REF.jackson.2012.144">Jackson et al 2012</a>] found that in 56 individuals with molecularly confirmed MED, <i>COMP</i> pathogenic variants accounted for 66%, <i>MATN3 for</i> 24%, <i>COL9A2</i> for 8%, and <i>COL9A3</i> for 2%. In contrast, a recent study of a Korean cohort identified pathogenic variants in 55 individuals as follows: <i>COMP</i> (43%), <i>MATN3</i> (55%), and <i>COL9A2</i> (2%) [<a class="bk_pop" href="#edm-ad.REF.kim.2011.2669">Kim et al 2011</a>]. This is in close agreement with a Japanese study that identified pathogenic variants in 19 individuals with MED: <i>COMP</i> (37%), <i>MATN3</i> (47%), <i>COL9A2</i> (11%), and <i>COL9A3</i> (5%). The high prevalence of <i>MATN3</i> pathogenic variants in these latter populations is believed to be the result of a common <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> (p.Arg121Trp), but this variant is also common in European populations. None of the three studies identified pathogenic variants in <i>COL9A1</i>.</p></div></dd><dt>4. </dt><dd><div id="edm-ad.TF.1.4"><p class="no_margin">The proportion of <i>COL9A1-3</i>, <i>COMP</i>, and <i>MATN3</i> pathogenic variants found in persons with MED is not well established. Previous studies have suggested frequencies of 10%-36% for <i>COMP</i> [<a class="bk_pop" href="#edm-ad.REF.jakkula.2005.292">Jakkula et al 2005</a>, <a class="bk_pop" href="#edm-ad.REF.kennedy.2005b.547">Kennedy et al 2005b</a>], 10% for <i>MATN3</i>, and 5% for the type IX collagen genes [<a class="bk_pop" href="#edm-ad.REF.briggs.2002.465">Briggs &#x00026; Chapman 2002</a>, <a class="bk_pop" href="#edm-ad.REF.jackson.2004.52">Jackson et al 2004</a>]. However, in a later study by the ESDN the proportion of MED caused by pathogenic variants in <i>COMP</i> increased to 81% when a strict clinical-radiographic review was undertaken before <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> was performed [<a class="bk_pop" href="#edm-ad.REF.zankl.2007.150">Zankl et al 2007</a>]. The success of this approach was confirmed by <a class="bk_pop" href="#edm-ad.REF.kim.2011.2669">Kim et al [2011]</a>, when pre-selection resulted in a variant detection rate of 87%.</p></div></dd><dt>5. </dt><dd><div id="edm-ad.TF.1.5"><p class="no_margin">See <a href="#edm-ad.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>6. </dt><dd><div id="edm-ad.TF.1.6"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>7. </dt><dd><div id="edm-ad.TF.1.7"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>8. </dt><dd><div id="edm-ad.TF.1.8"><p class="no_margin">All variants reported to date have been detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>.</p></div></dd><dt>9. </dt><dd><div id="edm-ad.TF.1.9"><p class="no_margin">No whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions or duplications involving <i>COL9A1</i>, <i>COL9A2</i>, <i>COL9A3</i>, or <i>COMP</i> have been reported to cause <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> MED.</p></div></dd><dt>10. </dt><dd><div id="edm-ad.TF.1.10"><p class="no_margin">No data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available.</p></div></dd><dt>11. </dt><dd><div id="edm-ad.TF.1.11"><p class="no_margin">Pathogenic variants remain undetected in approximately 20% of individuals with MED.</p></div></dd></dl></div></div></div></div></div></div><div id="edm-ad.Clinical_Characteristics"><h2 id="_edm-ad_Clinical_Characteristics_">Clinical Characteristics</h2><div id="edm-ad.Clinical_Description"><h3>Clinical Description</h3><p>Autosomal dominant multiple epiphyseal dysplasia (MED) was originally divided into a mild form called "Ribbing type" and a more severe form known as "Fairbank type." However, much more clinical variability exists within the overall MED <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> than is suggested by these two distinct entities. It is likely that the milder forms of MED either remain undiagnosed or are misdiagnosed as bilateral Perthes disease or even early-onset <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> osteoarthritis.</p><p><b>Presentation.</b> The presenting symptom early in childhood is usually pain in the hips and/or knees after exercise.</p><p>Affected children complain of fatigue with long-distance walking.</p><ul><li class="half_rhythm"><div>Waddling gait may be present.</div></li><li class="half_rhythm"><div>Angular deformities, including coxa vara and genu varum or genu valgum, are relatively rare.</div></li><li class="half_rhythm"><div>In contrast to the restricted mobility in the elbows, hypermobility in the knee and finger joints can be observed.</div></li></ul><p><b>Growth.</b> Adult height is either in the lower range of normal or mildly shortened. The shortness of the limbs relative to the trunk first becomes apparent in childhood. Head circumference is normal.</p><p><b>Progression.</b> The natural history of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> MED is of progressively worsening pain and joint deformity resulting in early-onset osteoarthritis. In adulthood, the condition is characterized by early-onset osteoarthritis, particularly of the large weight-bearing joints. In some individuals, the osteoarthritis is sufficiently severe to require joint replacement in early adult life.</p><p><b>Other.</b> No other anomalies are associated with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> MED. Intelligence is normal.</p></div><div id="edm-ad.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Studies of <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> have been relatively successful and can be summarized briefly [<a class="bk_pop" href="#edm-ad.REF.mortier.2001.606">Mortier et al 2001</a>, <a class="bk_pop" href="#edm-ad.REF.unger.2001.10">Unger et al 2001</a>]:</p><ul><li class="half_rhythm"><div>MED resulting from <i>COMP</i> pathogenic variants is characterized by significant involvement at the capital femoral epiphyses and irregular acetabula [<a class="bk_pop" href="#edm-ad.REF.unger.2001.10">Unger et al 2001</a>]. However, the recurrent <a class="figpopup" href="/books/NBK1123/table/edm-ad.T.pathogenic_comp_variants_discus/?report=objectonly" target="object" rid-figpopup="figedmadTpathogeniccompvariantsdiscus" rid-ob="figobedmadTpathogeniccompvariantsdiscus">p.Arg718Trp</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>COMP</i> appears to cause a mild form of the disorder, more consistent with MED caused by a type IX collagen <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> variant [<a class="bk_pop" href="#edm-ad.REF.jakkula.2003.942">Jakkula et al 2003</a>].</div></li><li class="half_rhythm"><div>Type IX collagen defects result in more severe involvement of the knees and relative sparing of the hips.</div></li><li class="half_rhythm"><div><i>MATN3</i> pathogenic variants result in knee abnormalities that are similar to those in individuals with a <i>COL9A2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; the hip abnormalities are more severe (although not as severe as those in individuals with a <i>COMP</i> pathogenic variant) [<a class="bk_pop" href="#edm-ad.REF.mortier.2001.606">Mortier et al 2001</a>]. However, more intra- and <a class="def" href="/books/n/gene/glossary/def-item/interfamilial-variability/">interfamilial variability</a> is evident in MED caused by <i>MATN3</i> pathogenic variants. A pathogenic variant such as <a class="figpopup" href="/books/NBK1123/table/edm-ad.T.pathogenic_matn3_variants_discu/?report=objectonly" target="object" rid-figpopup="figedmadTpathogenicmatn3variantsdiscu" rid-ob="figobedmadTpathogenicmatn3variantsdiscu">p.Arg121Trp</a> can result in a spectrum of clinical and radiographic features, suggesting that other genetic and/or environmental factors modify the severity of this particular form of MED [<a class="bk_pop" href="#edm-ad.REF.jackson.2004.52">Jackson et al 2004</a>, <a class="bk_pop" href="#edm-ad.REF.m_kitie.2004.278">M&#x000e4;kitie et al 2004</a>].</div></li></ul><p>It is important to note that striking intra- and <a class="def" href="/books/n/gene/glossary/def-item/interfamilial-variability/">interfamilial variability</a> can be observed in MED caused by pathogenic variants in <i>MATN3</i> [<a class="bk_pop" href="#edm-ad.REF.chapman.2001.393">Chapman et al 2001</a>, <a class="bk_pop" href="#edm-ad.REF.mortier.2001.606">Mortier et al 2001</a>, <a class="bk_pop" href="#edm-ad.REF.jackson.2004.52">Jackson et al 2004</a>, <a class="bk_pop" href="#edm-ad.REF.m_kitie.2004.278">M&#x000e4;kitie et al 2004</a>], in <i>COL9A3</i> [<a class="bk_pop" href="#edm-ad.REF.b_nnemann.2000.1212">B&#x000f6;nnemann et al 2000</a>, <a class="bk_pop" href="#edm-ad.REF.nakashima.2005.181">Nakashima et al 2005</a>], and in some instances, in <i>COMP</i>. These findings make the establishment of strong <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> in <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> MED a challenge.</p><p><a class="bk_pop" href="#edm-ad.REF.briggs.2014.1278">Briggs et al [2014]</a> reviewed 300 <i>COMP</i> variants and the resulting phenotypes published between 1995 and 2014 and concluded that pathogenic variants in specific residues and/or regions of the type III repeats of <i>COMP</i> are significantly associated with either MED or <a href="/books/n/gene/psach/">pseudoachondroplasia</a>.</p></div><div id="edm-ad.Penetrance"><h3>Penetrance</h3><p>There is some evidence for reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in MED caused by <i>MATN3</i> pathogenic variants [<a class="bk_pop" href="#edm-ad.REF.mortier.2001.606">Mortier et al 2001</a>, <a class="bk_pop" href="#edm-ad.REF.m_kitie.2004.278">M&#x000e4;kitie et al 2004</a>] while pathogenic variants in <i>COMP</i> and the type IX collagen genes are believed to be fully penetrant.</p></div><div id="edm-ad.Nomenclature"><h3>Nomenclature</h3><p>Multiple epiphyseal dysplasia was originally classified into the severe Fairbank type (MED-Fairbank) and milder Ribbing type (MED-Ribbing).</p><p>MED-Fairbank type is probably the same disease as "enchondral dysostosis" described by <a class="bk_pop" href="#edm-ad.REF.odman.1959.97">Odman [1959]</a>, and "microepiphyseal dysplasia" described by <a class="bk_pop" href="#edm-ad.REF.elsbach.1959.514">Elsbach [1959]</a>.</p><p>MED-Ribbing should not be confused with Ribbing disease (OMIM <a href="http://omim.org/entry/601477" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">601477</a>), a form of multiple diaphyseal sclerosis.</p></div><div id="edm-ad.Prevalence"><h3>Prevalence</h3><p>Studies undertaken to determine the birth prevalence of skeletal dysplasias suggest a prevalence of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> MED of at least one per 10,000 births. However, as MED is usually not diagnosed at birth, the figure is most likely an underestimate.</p></div></div><div id="edm-ad.Genetically_Related_Allelic_Disor"><h2 id="_edm-ad_Genetically_Related_Allelic_Disor_">Genetically Related (Allelic) Disorders</h2><div id="edm-ad.COMP"><h3><i>COMP</i></h3><p><a href="/books/n/gene/psach/"><b>Pseudoachondroplasia</b></a> shares clinical and radiographic abnormalities with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> MED and should be considered in the differential diagnosis. However, individuals with pseudoachondroplasia have short-limb dwarfism with spondyloepimetaphyseal involvement on radiographs. Unlike MED, pseudoachondroplasia is not known to be genetically heterogeneous and appears to result exclusively from pathogenic variants in <i>COMP</i>. Inheritance is autosomal dominant.</p><p>Pseudoachondroplasia was originally defined as a condition resembling <a href="/books/n/gene/achondroplasia/">achondroplasia</a> but with normal craniofacial features. Intelligence is normal. At birth, body length is usually normal. The diagnosis is often made between age one and three years when radiographic abnormalities are found, skeletal growth slows, and/or a waddling gait becomes apparent. Joint pain is common beginning in childhood particularly in the large joints of the lower extremities. Adult height ranges from 105 to 128 cm. Orthopedic complications are common. Affected individuals exhibit generalized ligamentous laxity, most pronounced in the fingers and knees. Laxity at the knees contributes significantly to leg deformities, including genu varum or genu valgum. Ligamentous laxity with odontoid hypoplasia can result in cervical spine instability. Degenerative joint disease is progressive. The radiographic manifestations involve the spine and epimetaphyseal regions of the tubular bones. Characteristic findings are the tongue-like projections on the anterior borders of the vertebral bodies (on lateral views of the spine), small proximal femoral epiphyses ("mini-epiphyses"), irregularly shaped carpal and tarsal bones, and short tubular bones with small and fragmented epiphyses and metaphyseal irregularities.</p></div><div id="edm-ad.COL9A13_MATN3"><h3><i>COL9A1-3, MATN3</i></h3><p>Other phenotypes associated with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in <i>COL9A1</i>, <i>COL9A2</i>, <i>COL9A3</i>, and <i>MATN3</i> are summarized in <a class="figpopup" href="/books/NBK1123/table/edm-ad.T.allelic_disorders/?report=objectonly" target="object" rid-figpopup="figedmadTallelicdisorders" rid-ob="figobedmadTallelicdisorders">Table 2</a>.</p><div id="edm-ad.T.allelic_disorders" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Allelic Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1123/table/edm-ad.T.allelic_disorders/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__edm-ad.T.allelic_disorders_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_edm-ad.T.allelic_disorders_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_edm-ad.T.allelic_disorders_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_edm-ad.T.allelic_disorders_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference</th><th id="hd_h_edm-ad.T.allelic_disorders_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_edm-ad.T.allelic_disorders_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COL9A1</i></td><td headers="hd_h_edm-ad.T.allelic_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Stickler syndrome</td><td headers="hd_h_edm-ad.T.allelic_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/stickler/">Stickler Syndrome</a></td><td headers="hd_h_edm-ad.T.allelic_disorders_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_edm-ad.T.allelic_disorders_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COL9A2</i><br /><i>COL9A3</i></td><td headers="hd_h_edm-ad.T.allelic_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Lumbar/intervertebral disk disease (IDD)</td><td headers="hd_h_edm-ad.T.allelic_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">OMIM <a href="http://omim.org/entry/603932" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">603932</a></td><td headers="hd_h_edm-ad.T.allelic_disorders_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>One of the most common musculoskeletal disorders in the world</div></li><li class="half_rhythm"><div>Specific <i>COL9A2</i> &#x00026; <i>COL9A3</i> alleles shown to confer susceptibility to IDD (typically associated w/sciatica) in Finnish population&#x000a0;<sup>1</sup></div></li></ul></td></tr><tr><td headers="hd_h_edm-ad.T.allelic_disorders_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>MATN3</i>&#x000a0;<sup>4</sup></td><td headers="hd_h_edm-ad.T.allelic_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Spondyloepimetaphyseal dysplasia (SEMD); matrilin-3 related</td><td headers="hd_h_edm-ad.T.allelic_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">OMIM <a href="http://omim.org/entry/608728" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">608728</a></td><td headers="hd_h_edm-ad.T.allelic_disorders_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Described in <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> family w/AR form of SEMD&#x000a0;<sup>2,&#x000a0;3</sup></div></li><li class="half_rhythm"><div>Affected persons presented w/disproportionate short stature, severe bowing of lower limbs, &#x00026; lumbar lordosis</div></li></ul></td></tr><tr><td headers="hd_h_edm-ad.T.allelic_disorders_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Hand osteoarthritis &#x00026; spinal disc degeneration</td><td headers="hd_h_edm-ad.T.allelic_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">OMIM <a href="http://omim.org/entry/140600" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">140600</a></td><td headers="hd_h_edm-ad.T.allelic_disorders_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>A p.Thr303Met substitution in the 1st EGF <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of <i>MATN3</i> implicated in pathogenesis of hand osteoarthritis&#x000a0;<sup>5</sup> &#x00026; spinal disc degeneration;&#x000a0;<sup>6</sup> the precise mechanism of this <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is unclear.&#x000a0;<sup>7</sup></div></li><li class="half_rhythm"><div>Follow-up studies support an association between <i>MATN3</i> polymorphisms &#x00026; osteoarthritis in the Chinese Han population&#x000a0;<sup>8</sup> &#x00026; w/vertebral fracture in Chinese postmenopausal women.&#x000a0;<sup>9</sup></div></li></ul></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a></p></div></dd><dt>1. </dt><dd><div id="edm-ad.TF.2.1"><p class="no_margin"><a class="bk_pop" href="#edm-ad.REF.annunen.1999.409">Annunen et al [1999]</a>, <a class="bk_pop" href="#edm-ad.REF.paassilta.2001.1843">Paassilta et al [2001]</a></p></div></dd><dt>2. </dt><dd><div id="edm-ad.TF.2.2"><p class="no_margin"><a class="bk_pop" href="#edm-ad.REF.borochowitz.2004.366">Borochowitz et al [2004]</a></p></div></dd><dt>3. </dt><dd><div id="edm-ad.TF.2.3"><p class="no_margin">All <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> members of this family were <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for a p.Cys304Ser <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the first EGF <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of matrilin-3 (<i>MATN3</i>). Previous studies have demonstrated that p.Cys304Ser causes the intracellular retention of misfolded matrilin-3 [<a class="bk_pop" href="#edm-ad.REF.otten.2005.774">Otten et al 2005</a>], suggesting that this is a key disease mechanism and is therefore another example of an ER stress-related skeletal disease [<a class="bk_pop" href="#edm-ad.REF.briggs.2015.1137">Briggs et al 2015</a>].</p></div></dd><dt>4. </dt><dd><div id="edm-ad.TF.2.4"><p class="no_margin">Studies have shown that the p.Thr303Met variant allows the secretion of matrilin-3 [<a class="bk_pop" href="#edm-ad.REF.otten.2005.774">Otten et al 2005</a>] and does not affect collagen affinity, but can promote the formation of wider collagen fibrils in cartilage [<a class="bk_pop" href="#edm-ad.REF.otten.2010.254">Otten et al 2010</a>].</p></div></dd><dt>5. </dt><dd><div id="edm-ad.TF.2.5"><p class="no_margin"><a class="bk_pop" href="#edm-ad.REF.stef_nsson.2003.1448">Stef&#x000e1;nsson et al [2003]</a>, <a class="bk_pop" href="#edm-ad.REF.pullig.2007.279">Pullig et al [2007]</a></p></div></dd><dt>6. </dt><dd><div id="edm-ad.TF.2.6"><p class="no_margin"><a class="bk_pop" href="#edm-ad.REF.min.2006.1060">Min et al [2006]</a></p></div></dd><dt>7. </dt><dd><div id="edm-ad.TF.2.7"><p class="no_margin"><a class="bk_pop" href="#edm-ad.REF.otten.2005.774">Otten et al [2005]</a></p></div></dd><dt>8. </dt><dd><div id="edm-ad.TF.2.8"><p class="no_margin"><a class="bk_pop" href="#edm-ad.REF.gu.2012.656084">Gu et al [2012]</a></p></div></dd><dt>9. </dt><dd><div id="edm-ad.TF.2.9"><p class="no_margin"><a class="bk_pop" href="#edm-ad.REF.zhao.2012.917">Zhao et al [2012]</a></p></div></dd></dl></div></div></div></div></div><div id="edm-ad.Differential_Diagnosis"><h2 id="_edm-ad_Differential_Diagnosis_">Differential Diagnosis</h2><p>Other disorders with features that overlap with those of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> multiple epiphyseal dysplasia (MED) are summarized in <a class="figpopup" href="/books/NBK1123/table/edm-ad.T.disorders_to_consider_in_the_di/?report=objectonly" target="object" rid-figpopup="figedmadTdisorderstoconsiderinthedi" rid-ob="figobedmadTdisorderstoconsiderinthedi">Table 3</a>.</p><div id="edm-ad.T.disorders_to_consider_in_the_di" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Disorders to Consider in the Differential Diagnosis of Autosomal Dominant Multiple Epiphyseal Dysplasia (MED)</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1123/table/edm-ad.T.disorders_to_consider_in_the_di/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__edm-ad.T.disorders_to_consider_in_the_di_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_edm-ad.T.disorders_to_consider_in_the_di_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_edm-ad.T.disorders_to_consider_in_the_di_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_edm-ad.T.disorders_to_consider_in_the_di_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_edm-ad.T.disorders_to_consider_in_the_di_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Characteristic Radiographic Features</th><th id="hd_h_edm-ad.T.disorders_to_consider_in_the_di_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Overlapping Clinical Features</th><th id="hd_h_edm-ad.T.disorders_to_consider_in_the_di_1_1_1_6" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comments</th></tr></thead><tbody><tr><td headers="hd_h_edm-ad.T.disorders_to_consider_in_the_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/edm/">Multiple epiphyseal dysplasia, recessive</a> (EDM4/rMED)</td><td headers="hd_h_edm-ad.T.disorders_to_consider_in_the_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC26A2</i></td><td headers="hd_h_edm-ad.T.disorders_to_consider_in_the_di_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_edm-ad.T.disorders_to_consider_in_the_di_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Double-layered patella (i.e., presence of a separate anterior &#x00026; posterior ossification layer) observed on lateral knee radiographs in ~60% (finding appears to be age related &#x00026; may not be apparent in adults)</td><td headers="hd_h_edm-ad.T.disorders_to_consider_in_the_di_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Joint pain (usually in hips &#x00026;/or knees); malformations of hands, feet, &#x00026; knees; scoliosis</div></li><li class="half_rhythm"><div>Onset of articular pain variable, but usually in late childhood</div></li><li class="half_rhythm"><div>Stature usually w/in normal range prior to puberty; in adulthood, stature only slightly diminished (range: 150-180 cm)</div></li><li class="half_rhythm"><div>Mild functional disability</div></li></ul></td><td headers="hd_h_edm-ad.T.disorders_to_consider_in_the_di_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~50% have an abnormal finding at birth, incl clubfoot, clinodactyly, or (rarely) cystic ear swelling.</td></tr><tr><td headers="hd_h_edm-ad.T.disorders_to_consider_in_the_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Legg-Calve-Perthes (LCPD)<br />(OMIM <a href="http://omim.org/entry/150600" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">150600</a>)</td><td headers="hd_h_edm-ad.T.disorders_to_consider_in_the_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COL2A1</i></td><td headers="hd_h_edm-ad.T.disorders_to_consider_in_the_di_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_edm-ad.T.disorders_to_consider_in_the_di_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Radiographic changes observed in LCPD differ from those of MED, w/more involvement of metaphyses &#x00026; femoral neck.</td><td headers="hd_h_edm-ad.T.disorders_to_consider_in_the_di_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hip pain</td><td headers="hd_h_edm-ad.T.disorders_to_consider_in_the_di_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Juvenile osteonecrosis of the femoral head caused by disruption of blood supply during endochondral ossification</div></li><li class="half_rhythm"><div>Usually affects males ages 3-15 yrs</div></li><li class="half_rhythm"><div>Up to 20% have bilateral involvement.</div></li><li class="half_rhythm"><div>Several studies have identified differences between bilateral &#x00026; unilateral LCPD (Of note, bilateral LCPD is more severe).</div></li></ul></td></tr><tr><td headers="hd_h_edm-ad.T.disorders_to_consider_in_the_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mild spondyloepiphyseal dysplasia congenita (SEDc)<br />(OMIM <a href="http://omim.org/entry/183900" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">183900</a>)</td><td headers="hd_h_edm-ad.T.disorders_to_consider_in_the_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COL2A1</i></td><td headers="hd_h_edm-ad.T.disorders_to_consider_in_the_di_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_edm-ad.T.disorders_to_consider_in_the_di_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_edm-ad.T.disorders_to_consider_in_the_di_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COL2A1</i> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants identified in 2 persons w/mild SEDc &#x00026; phenotypic features consistent w/MED based on limited clinical data &#x00026; radiographic images&#x000a0;<sup>2</sup></td><td headers="hd_h_edm-ad.T.disorders_to_consider_in_the_di_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_edm-ad.T.disorders_to_consider_in_the_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Beukes <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> hip dysplasia (BFHD)&#x000a0;<sup>3</sup><br />(OMIM <a href="http://omim.org/entry/142669" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">142669</a>)</td><td headers="hd_h_edm-ad.T.disorders_to_consider_in_the_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>UFSP2</i></td><td headers="hd_h_edm-ad.T.disorders_to_consider_in_the_di_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_edm-ad.T.disorders_to_consider_in_the_di_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_edm-ad.T.disorders_to_consider_in_the_di_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Shares many clinical &#x00026; radiographic features w/MED &#x00026; is now recognized as a form of MED&#x000a0;<sup>3</sup></td><td headers="hd_h_edm-ad.T.disorders_to_consider_in_the_di_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">First identified in 47 persons in 6 generations of an Afrikaner family in South Africa&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_edm-ad.T.disorders_to_consider_in_the_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/psach/">Pseudoachondroplasia</a></td><td headers="hd_h_edm-ad.T.disorders_to_consider_in_the_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COMP</i></td><td headers="hd_h_edm-ad.T.disorders_to_consider_in_the_di_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_edm-ad.T.disorders_to_consider_in_the_di_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See <a href="#edm-ad.Genetically_Related_Allelic_Disor">Genetically Related Disorders</a>.</td><td headers="hd_h_edm-ad.T.disorders_to_consider_in_the_di_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See <a href="#edm-ad.Genetically_Related_Allelic_Disor">Genetically Related Disorders</a>.</td><td headers="hd_h_edm-ad.T.disorders_to_consider_in_the_di_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="edm-ad.TF.3.1"><p class="no_margin">Some forms of LCPD have been shown to result from a recurrent p.Gly1170Ser variant in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 50 of <i>COL2A1</i> [<a class="bk_pop" href="#edm-ad.REF.liu.2005.2294">Liu et al 2005</a>] while other <i>COL2A1</i> pathogenic variants, such as p.Gly393Ser [<a class="bk_pop" href="#edm-ad.REF.kannu.2011.1785">Kannu et al 2011</a>] and p.Gly717Ser [<a class="bk_pop" href="#edm-ad.REF.miyamoto.2007.625">Miyamoto et al 2007</a>], have also been associated with LCPD and avascular necrosis of the femoral head.</p></div></dd><dt>2. </dt><dd><div id="edm-ad.TF.3.2"><p class="no_margin"><a class="bk_pop" href="#edm-ad.REF.jackson.2012.144">Jackson et al [2012]</a></p></div></dd><dt>3. </dt><dd><div id="edm-ad.TF.3.3"><p class="no_margin">The International Nosology and Classification of Genetic Skeletal Disorders &#x02013; 2015 Revision recognized BFHD as a form of MED [<a class="bk_pop" href="#edm-ad.REF.bonafe.2015.2869">Bonafe et al 2015</a>].</p></div></dd><dt>4. </dt><dd><div id="edm-ad.TF.3.4"><p class="no_margin"><a class="bk_pop" href="#edm-ad.REF.cilliers.1990.386">Cilliers &#x00026; Beighton [1990]</a>, <a class="bk_pop" href="#edm-ad.REF.watson.2015.558">Watson et al [2015]</a></p></div></dd></dl></div></div></div></div><div id="edm-ad.Management"><h2 id="_edm-ad_Management_">Management</h2><div id="edm-ad.Evaluations_Following_Initial_Dia"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with multiple epiphyseal dysplasia (MED), the evaluations summarized in this section (if not performed as part of the evaluation that led to the diagnosis) are recommended:</p><ul><li class="half_rhythm"><div>Elicitation of pain history</div></li><li class="half_rhythm"><div>Assessment of joint mobility</div></li><li class="half_rhythm"><div>Radiographs to determine the extent and severity of joint involvement</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="edm-ad.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>For pain control, a combination of analgesics and physiotherapy including hydrotherapy is helpful to many <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals; however, pain can be difficult to control. Referral to a rheumatologist or pain specialist may be indicated.</p><p>Limitation of joint destruction and the development of osteoarthritis is a goal. Consultation with an orthopedic surgeon can determine if realignment osteotomy and/or acetabular osteotomy may be helpful in slowing the progression of symptoms.</p><p>In some individuals, total joint arthroplasty may be required if the degenerative hip changes are causing too much pain or dysfunction.</p><p>Psychosocial support addressing issues of short stature, chronic pain, disability, and employment is appropriate.</p></div><div id="edm-ad.Surveillance"><h3>Surveillance</h3><p>Evaluation by an orthopedic surgeon is recommended if the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has chronic pain or limb deformities (genu varum, genu valgum).</p></div><div id="edm-ad.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>The following should be avoided:</p><ul><li class="half_rhythm"><div>Obesity, which increases stress on joints</div></li><li class="half_rhythm"><div>Exercise that causes repetitive strain on affected joints</div></li></ul></div><div id="edm-ad.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#edm-ad.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="edm-ad.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="edm-ad.Genetic_Counseling"><h2 id="_edm-ad_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="edm-ad.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Dominant multiple epiphyseal dysplasia (MED) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="edm-ad.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Many individuals with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> MED have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> MED may have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>COL9A1</i>, <i>COL9A2</i>, <i>COL9A3</i>, <i>COMP</i>, or <i>MATN3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The proportion of cases caused by a <i>de novo</i> pathogenic variant is unknown.</div></li><li class="half_rhythm"><div>Recommendations for the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> may include evaluation for signs of MED or early-onset osteoarthritis and, if a pathogenic variant has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a known <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> that cannot be detected in the leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent. Germline mosaicism has been reported in a number of families [<a class="bk_pop" href="#edm-ad.REF.jackson.2004.52">Jackson et al 2004</a>].</div></li><li class="half_rhythm"><div>Note: If the parent is the individual in whom the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> first occurred, s/he may have <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for the variant and may be mildly/minimally <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to sibs of the proband depends on the clinical/genetic status of the proband's parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> MED and/or is known to have the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in the proband, the risk to sibs is 50%.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a known <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> that cannot be detected in the leukocyte DNA of either parent, the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is slightly greater than that of the general population because of the possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>; germline mosaicism has been reported in a number of families [<a class="bk_pop" href="#edm-ad.REF.jackson.2004.52">Jackson et al 2004</a>].</div></li><li class="half_rhythm"><div>If the parents have not been tested for the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> but are clinically unaffected, the risk to the sibs of a proband appears to be low. However, the sibs of a proband with clinically unaffected parents are still at increased risk for <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> MED because of the possibility of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> parent (see <a href="#edm-ad.Penetrance">Penetrance</a>) or the possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> MED has a 50% chance of inheriting the <i>COL9A1</i>, <i>COL9A2</i>, <i>COL9A3</i>, <i>COMP</i>, or <i>MATN3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, his or her family members may be at risk.</p></div><div id="edm-ad.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>MED of unknown <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a></b></p><ul><li class="half_rhythm"><div>Until the <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a> in an individual with MED can be determined, it may be appropriate to consider that the risk of transmitting the disorder to each of the offspring is as high as 50%.</div></li><li class="half_rhythm"><div>A number of families in which one of the parents has <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> for a dominantly inherited <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have been reported, resulting in a family history suggestive of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance.</div></li></ul><p><b>Testing of asymptomatic at-risk individuals younger than age 18</b> years is controversial. Testing may be appropriate if it is believed that knowledge of the disease status will influence care of the child. Since early orthopedic intervention and limitation of inappropriate exercise may ameliorate the severity of joint disease in the long term, it has been argued that predictive testing is justified in children at risk for MED.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="edm-ad.Prenatal_Testing_and_Preimplantat"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>COL9A1</i>, <i>COL9A2</i>, <i>COL9A3</i>, <i>COMP</i>, or <i>MATN3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> multiple epiphyseal dysplasia are possible.</p></div></div><div id="edm-ad.Resources"><h2 id="_edm-ad_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Little People of America, Inc. (LPA)</b></div><div>250 El Camino Real</div><div>Suite 201</div><div>Tustin CA 92780</div><div><b>Phone:</b> 888-572-2001 (toll-free); 714-368-3689</div><div><b>Fax:</b> 714-368-3367</div><div><b>Email:</b> info@lpaonline.org</div><div><a href="http://www.lpaonline.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.lpaonline.org</a></div></li><li class="half_rhythm"><div><b>Restricted Growth Association (RGA)</b></div><div>PO Box 15755</div><div>Solihull B93 3FY</div><div>United Kingdom</div><div><b>Phone:</b> +44 0300 111 1970</div><div><b>Fax:</b> +44 0300 111 2454</div><div><b>Email:</b> office@restrictedgrowth.co.uk</div><div><a href="http://www.restrictedgrowth.co.uk" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.restrictedgrowth.co.uk</a></div></li><li class="half_rhythm"><div><b>International Skeletal Dysplasia Registry</b></div><div>UCLA</div><div>615 Charles E. Young Drive</div><div>South Room 410</div><div>Los Angeles CA 90095-7358</div><div><b>Phone:</b> 310-825-8998</div><div><b>Fax:</b> 310-206-5266</div><div><b>Email:</b> Salon@mednet.ucla.edu</div><div><a href="https://www.uclahealth.org/ortho/isdr" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">International Skeletal Dysplasia Registry</a></div></li><li class="half_rhythm"><div><b>Skeletal Dysplasia Network, European (ESDN)</b></div><div>Institute of Genetic Medicine</div><div>Newcastle University, International Centre for Life</div><div>Central Parkway</div><div> Newcastle upon Tyne NE1 3BZ</div><div>United Kingdom</div><div><b>Email:</b> info@esdn.org</div><div><a href="http://www.esdn.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.esdn.org</a></div></li></ul></div><div id="edm-ad.Molecular_Genetics"><h2 id="_edm-ad_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="edm-ad.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Multiple Epiphyseal Dysplasia, Dominant: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1123/table/edm-ad.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__edm-ad.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_edm-ad.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_edm-ad.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_edm-ad.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_edm-ad.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_edm-ad.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_edm-ad.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_edm-ad.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1297" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>COL9A1</i></a></td><td headers="hd_b_edm-ad.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1297" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">6q13</a></td><td headers="hd_b_edm-ad.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P20849" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Collagen alpha-1(IX) chain</a></td><td headers="hd_b_edm-ad.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/COL9A1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COL9A1 database</a></td><td headers="hd_b_edm-ad.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=COL9A1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COL9A1</a></td><td headers="hd_b_edm-ad.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=COL9A1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COL9A1</a></td></tr><tr><td headers="hd_b_edm-ad.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1298" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>COL9A2</i></a></td><td headers="hd_b_edm-ad.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1298" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">1p34<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_edm-ad.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q14055" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Collagen alpha-2(IX) chain</a></td><td headers="hd_b_edm-ad.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/COL9A2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COL9A2 database</a></td><td headers="hd_b_edm-ad.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=COL9A2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COL9A2</a></td><td headers="hd_b_edm-ad.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=COL9A2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COL9A2</a></td></tr><tr><td headers="hd_b_edm-ad.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1299" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>COL9A3</i></a></td><td headers="hd_b_edm-ad.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1299" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">20q13<wbr style="display:inline-block"></wbr>​.33</a></td><td headers="hd_b_edm-ad.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q14050" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Collagen alpha-3(IX) chain</a></td><td headers="hd_b_edm-ad.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/COL9A3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COL9A3 database</a></td><td headers="hd_b_edm-ad.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=COL9A3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COL9A3</a></td><td headers="hd_b_edm-ad.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=COL9A3[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COL9A3</a></td></tr><tr><td headers="hd_b_edm-ad.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1311" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>COMP</i></a></td><td headers="hd_b_edm-ad.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1311" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">19p13<wbr style="display:inline-block"></wbr>​.11</a></td><td headers="hd_b_edm-ad.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P49747" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Cartilage oligomeric matrix protein</a></td><td headers="hd_b_edm-ad.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/COMP" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COMP database</a></td><td headers="hd_b_edm-ad.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=COMP" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COMP</a></td><td headers="hd_b_edm-ad.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=COMP[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COMP</a></td></tr><tr><td headers="hd_b_edm-ad.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/4148" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>MATN3</i></a></td><td headers="hd_b_edm-ad.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=4148" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">2p24<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_edm-ad.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O15232" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Matrilin-3</a></td><td headers="hd_b_edm-ad.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/MATN3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MATN3 database</a></td><td headers="hd_b_edm-ad.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=MATN3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MATN3</a></td><td headers="hd_b_edm-ad.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=MATN3[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MATN3</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="edm-ad.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="edm-ad.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Multiple Epiphyseal Dysplasia, Dominant (<a href="/omim/120210,120260,120270,132400,600204,600310,600969,602109,607078,614135" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1123/table/edm-ad.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__edm-ad.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/120210" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">120210</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">COLLAGEN, TYPE IX, ALPHA-1; COL9A1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/120260" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">120260</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">COLLAGEN, TYPE IX, ALPHA-2; COL9A2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/120270" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">120270</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">COLLAGEN, TYPE IX, ALPHA-3; COL9A3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/132400" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">132400</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EPIPHYSEAL DYSPLASIA, MULTIPLE, 1; EDM1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/600204" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">600204</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EPIPHYSEAL DYSPLASIA, MULTIPLE, 2; EDM2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/600310" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">600310</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CARTILAGE OLIGOMERIC MATRIX PROTEIN; COMP</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/600969" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">600969</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EPIPHYSEAL DYSPLASIA, MULTIPLE, 3; EDM3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/602109" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">602109</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MATRILIN 3; MATN3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/607078" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">607078</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EPIPHYSEAL DYSPLASIA, MULTIPLE, 5; EDM5</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614135" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614135</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EPIPHYSEAL DYSPLASIA, MULTIPLE, 6; EDM6</td></tr></tbody></table></div></div><div id="edm-ad.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>The five genes (<i>COL9A1</i>, <i>COL9A2</i>, <i>COL9A3</i>, <i>COMP</i>, and <i>MATN3</i>) in which pathogenic variants cause <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> multiple epiphyseal dysplasia (MED) encode three structural macromolecules of the cartilage extracellular matrix (type IX collagen, cartilage oligomeric matrix protein, and matrilin-3) [<a class="bk_pop" href="#edm-ad.REF.unger.2001.244">Unger &#x00026; Hecht 2001</a>, <a class="bk_pop" href="#edm-ad.REF.briggs.2002.465">Briggs &#x00026; Chapman 2002</a>]. These proteins interact with each other and with type II collagen both in vitro [<a class="bk_pop" href="#edm-ad.REF.rosenberg.1998.20397">Rosenberg et al 1998</a>, <a class="bk_pop" href="#edm-ad.REF.holden.2001.6046">Holden et al 2001</a>, <a class="bk_pop" href="#edm-ad.REF.thur.2001.6083">Thur et al 2001</a>, <a class="bk_pop" href="#edm-ad.REF.mann.2004.25294">Mann et al 2004</a>, <a class="bk_pop" href="#edm-ad.REF.budde.2005.10465">Budde et al 2005</a>, <a class="bk_pop" href="#edm-ad.REF.wagener.2005.3323">Wagener et al 2005</a>, <a class="bk_pop" href="#edm-ad.REF.fresquet.2007.34634">Fresquet et al 2007</a>, <a class="bk_pop" href="#edm-ad.REF.fresquet.2008.330">Fresquet et al 2008</a>, <a class="bk_pop" href="#edm-ad.REF.fresquet.2010.34048">Fresquet et al 2010</a>] and in vivo [<a class="bk_pop" href="#edm-ad.REF.budde.2005.10465">Budde et al 2005</a>, <a class="bk_pop" href="#edm-ad.REF.blumbach.2008.306">Blumbach et al 2008</a>, <a class="bk_pop" href="#edm-ad.REF.zaucke.2009.1067">Zaucke &#x00026; Gr&#x000e4;ssel 2009</a>].</p><div id="edm-ad.Collagen_IX_Genes"><h4>Collagen IX Genes</h4><p><b>Gene structure.</b> The coding sequence of <i>COL9A1</i> is organized into 38 exons spanning approximately 90 kb [<a class="bk_pop" href="#edm-ad.REF.pihlajamaa.1998.237">Pihlajamaa et al 1998</a>]; the coding sequence of <i>COL9A2</i> and <i>COL9A3</i> is organized into 32 exons spanning approximately 15 kb and 23 kb, respectively [<a class="bk_pop" href="#edm-ad.REF.paassilta.1999.22469">Paassilta et al 1999</a>]. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1123/#edm-ad.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Pathogenic variants in <i>COL9A</i> genes cause MED (<a href="/books/NBK1123/#edm-ad.molgen.TB">Table B</a>). All reported MED-associated pathogenic variants are clustered in one of the followng:</p><ul><li class="half_rhythm"><div>The splice donor site of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 3 of <i>COL9A2</i></div></li><li class="half_rhythm"><div>The splice acceptor site of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 3 of <i>COL9A3</i></div></li><li class="half_rhythm"><div>The splice acceptor site of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 8 of <i>COL9A1</i></div></li></ul><p>Both <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 3 pathogenic variants result in exon 3 skipping during RNA <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a>; the resulting 36-bp <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> in the <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> translates to a 12-amino acid <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> deletion from the encoded protein. The exon 8 <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>COL9A1</i> results in a complex splicing pattern in which exon 8 (75 bp), exon 10 (63 bp), or both exons 8 and 10 (138 bp) are deleted, giving rise to the in-frame deletion of 25, 21, or 49 amino acids. All of the deletions are located in a similar region of the COL3 <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of type IX collagen, demonstrating the importance of this domain [<a class="bk_pop" href="#edm-ad.REF.unger.2001.244">Unger &#x00026; Hecht 2001</a>, <a class="bk_pop" href="#edm-ad.REF.briggs.2002.465">Briggs &#x00026; Chapman 2002</a>].</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Type IX collagen, a heterotrimer [&#x003b1;1(IX)&#x003b1;2(IX)&#x003b1;3(IX)] of polypeptides encoded by <i>COL9A1</i>, <i>COL9A2</i>, and <i>COL9A3</i>, is an integral component of cartilage and a member of the FACIT (<i>f</i>ibril-<i>a</i>ssociated <i>c</i>ollagen with <i>i</i>nterrupted <i>t</i>riple helix) group of collagens. Type IX collagen has three collagenous (COL) domains separated by non-collagenous (NC) domains. The amino-terminal NC <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (NC4) is encoded entirely by <i>COL9A1</i>. The collagenous domains (COL1-COL3) are separated by four non-collagenous (NC1-NC4) domains. The COL domains closely associate with type II collagen fibrils and are thought to act as a molecular bridge between collagen fibrils and other cartilage matrix components.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a>-skipping pathogenic variants in <i>COL9</i> (see <b>Pathogenic variants</b>) result in <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of amino acids from the COL3 <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, which may affect its ability to fold correctly or interact with other components of the cartilage extracellular matrix [<a class="bk_pop" href="#edm-ad.REF.fresquet.2007.34634">Fresquet et al 2007</a>].</p><p>Studies have confirmed that a <i>COL9A3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> indeed abolishes binding of type IX collagen to matrilin-3 and type II collagen, thus identifying for the first time a molecular consequence of these pathogenic variants [<a class="bk_pop" href="#edm-ad.REF.fresquet.2007.34634">Fresquet et al 2007</a>].</p></div><div id="edm-ad.COMP_1"><h4><i>COMP</i></h4><p><b>Gene structure.</b> The coding sequence of <i>COMP</i> is organized into 19 exons spanning approximately 8.5 kb. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1123/#edm-ad.molgen.TA">Table A</a>, <b>Gene</b>. Exons 8-14 encode the type III repeats and exons 15-19 encode the C-terminal <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (see <b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a></b>) [<a class="bk_pop" href="#edm-ad.REF.unger.2001.244">Unger &#x00026; Hecht 2001</a>, <a class="bk_pop" href="#edm-ad.REF.briggs.2002.465">Briggs &#x00026; Chapman 2002</a>].</p><p><b>Pathogenic variants.</b> All of the pathogenic variants identified in <i>COMP</i> that result in MED are either <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants or small <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> deletions and duplications found in the type III repeats (85%) or C-terminal <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (15%) of <i>COMP</i> [<a class="bk_pop" href="#edm-ad.REF.kennedy.2005a.593">Kennedy et al 2005a</a>, <a class="bk_pop" href="#edm-ad.REF.kennedy.2005b.547">Kennedy et al 2005b</a>, <a class="bk_pop" href="#edm-ad.REF.jackson.2012.144">Jackson et al 2012</a>]. To date, nearly 100 different pathogenic missense variants have been reported in these two domains.</p><p>Small <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> deletions (p.Arg367_Gly368del and p.Asn386del) and <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> (p.Asp473dup) in the type III repeat region have been reported. Recurrent pathogenic variants in the type III repeat region include p.Asp385Asn and p.Asn523Lys. A number of C-terminal <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants have been identified; they include p.Asn555Lys, p.Asp605Asn, p.Ser681Cys, p.Arg718Pro, and the recurrent p.Arg718Trp [<a class="bk_pop" href="#edm-ad.REF.kennedy.2005a.593">Kennedy et al 2005a</a>, <a class="bk_pop" href="#edm-ad.REF.jackson.2012.144">Jackson et al 2012</a>]. Two variants (p.Thr585Arg and p.Thr585Met) have been shown to result in either mild pseudoachondroplasia or MED, confirming that the two disorders are related. See <a class="figpopup" href="/books/NBK1123/table/edm-ad.T.pathogenic_comp_variants_discus/?report=objectonly" target="object" rid-figpopup="figedmadTpathogeniccompvariantsdiscus" rid-ob="figobedmadTpathogeniccompvariantsdiscus">Table 4</a>.</p><p>More recently a putative variant (p.Gly167Glu) has been identified in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 5 of <i>COMP</i>, which encodes residues of the second epidermal growth factor (EGF)-like repeat of <i>COMP</i> [<a class="bk_pop" href="#edm-ad.REF.jackson.2012.144">Jackson et al 2012</a>]. A previous study by <a class="bk_pop" href="#edm-ad.REF.kennedy.2005b.547">Kennedy et al [2005b]</a> demonstrated that approximately 70% of MED-causing variants in <i>COMP</i> reside in exons 10, 11, and 13, a finding confirmed by a recent study [<a class="bk_pop" href="#edm-ad.REF.jackson.2012.144">Jackson et al 2012</a>], which also reaffirmed that MED-causing variants are not found in exons 15, 17, and 19 of <i>COMP</i>.</p><div id="edm-ad.T.pathogenic_comp_variants_discus" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Pathogenic <i>COMP</i> Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1123/table/edm-ad.T.pathogenic_comp_variants_discus/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__edm-ad.T.pathogenic_comp_variants_discus_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_edm-ad.T.pathogenic_comp_variants_discus_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_edm-ad.T.pathogenic_comp_variants_discus_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_edm-ad.T.pathogenic_comp_variants_discus_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_edm-ad.T.pathogenic_comp_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.500G&#x0003e;A</td><td headers="hd_h_edm-ad.T.pathogenic_comp_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly167Glu</td><td headers="hd_h_edm-ad.T.pathogenic_comp_variants_discus_1_1_1_3" rowspan="13" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/40217842" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000095<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="/protein/40217843" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000086<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_edm-ad.T.pathogenic_comp_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1099_1104del</td><td headers="hd_h_edm-ad.T.pathogenic_comp_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg367_Gly368del</td></tr><tr><td headers="hd_h_edm-ad.T.pathogenic_comp_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1153G&#x0003e;A</td><td headers="hd_h_edm-ad.T.pathogenic_comp_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp385Asn</td></tr><tr><td headers="hd_h_edm-ad.T.pathogenic_comp_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1156_1158del</td><td headers="hd_h_edm-ad.T.pathogenic_comp_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn386del</td></tr><tr><td headers="hd_h_edm-ad.T.pathogenic_comp_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1417_1419dup</td><td headers="hd_h_edm-ad.T.pathogenic_comp_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp473dup</td></tr><tr><td headers="hd_h_edm-ad.T.pathogenic_comp_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1569C&#x0003e;G</td><td headers="hd_h_edm-ad.T.pathogenic_comp_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn523Lys</td></tr><tr><td headers="hd_h_edm-ad.T.pathogenic_comp_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1665C&#x0003e;A</td><td headers="hd_h_edm-ad.T.pathogenic_comp_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn555Lys</td></tr><tr><td headers="hd_h_edm-ad.T.pathogenic_comp_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1754C&#x0003e;G</td><td headers="hd_h_edm-ad.T.pathogenic_comp_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr585Arg</td></tr><tr><td headers="hd_h_edm-ad.T.pathogenic_comp_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1754C&#x0003e;T</td><td headers="hd_h_edm-ad.T.pathogenic_comp_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr585Met</td></tr><tr><td headers="hd_h_edm-ad.T.pathogenic_comp_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1813G&#x0003e;A</td><td headers="hd_h_edm-ad.T.pathogenic_comp_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp605Asn</td></tr><tr><td headers="hd_h_edm-ad.T.pathogenic_comp_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2042C&#x0003e;G</td><td headers="hd_h_edm-ad.T.pathogenic_comp_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser681Cys</td></tr><tr><td headers="hd_h_edm-ad.T.pathogenic_comp_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2153G&#x0003e;C</td><td headers="hd_h_edm-ad.T.pathogenic_comp_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg718Pro</td></tr><tr><td headers="hd_h_edm-ad.T.pathogenic_comp_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2152C&#x0003e;T</td><td headers="hd_h_edm-ad.T.pathogenic_comp_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg718Trp</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> COMP is a 550-kd protein of 757 amino acids. It is a pentameric adhesive glycoprotein found predominantly in the extracellular matrix (ECM) of cartilage but also in tendon and ligament. It is a member of the thrombospondin protein family comprising:</p><ul><li class="half_rhythm"><div>A coiled-coil oligomerization <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a></div></li><li class="half_rhythm"><div>Four type II (EGF-like) repeats</div></li><li class="half_rhythm"><div>Eight type III (CaM-like) repeats</div></li><li class="half_rhythm"><div>A large COOH-terminal globular <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a></div></li></ul><p>The type III repeats bind Ca2+ cooperatively and with high affinity, while the C-terminal globular <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> has the ability to interact with both fibrillar (type I, II, and III) and nonfibrillar collagens, such as type IX [<a class="bk_pop" href="#edm-ad.REF.rosenberg.1998.20397">Rosenberg et al 1998</a>, <a class="bk_pop" href="#edm-ad.REF.holden.2001.6046">Holden et al 2001</a>, <a class="bk_pop" href="#edm-ad.REF.thur.2001.6083">Thur et al 2001</a>, <a class="bk_pop" href="#edm-ad.REF.mann.2004.25294">Mann et al 2004</a>], and fibronectin [<a class="bk_pop" href="#edm-ad.REF.di_cesare.2002.461">Di Cesare et al 2002</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic variants in the type III repeats result in the misfolding of the protein and its retention in the rough endoplasmic reticulum (rER) of chondrocytes, likely resulting in ER stress and an unfolded protein response and cell death [<a class="bk_pop" href="#edm-ad.REF.chen.2000.26538">Chen et al 2000</a>, <a class="bk_pop" href="#edm-ad.REF.maddox.2000.11412">Maddox et al 2000</a>, <a class="bk_pop" href="#edm-ad.REF.unger.2001.244">Unger &#x00026; Hecht 2001</a>, <a class="bk_pop" href="#edm-ad.REF.kleerekoper.2002.10581">Kleerekoper et al 2002</a>]. The effect of pathogenic variants in the C-terminal <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> is not fully resolved, but these pathogenic variants do not always prevent the secretion of abnormal protein in vitro [<a class="bk_pop" href="#edm-ad.REF.spitznagel.2004.479">Spitznagel et al 2004</a>, <a class="bk_pop" href="#edm-ad.REF.schmitz.2006.32587">Schmitz et al 2006</a>] or in vivo [<a class="bk_pop" href="#edm-ad.REF.pir_ggarcia.2007.2072">Pir&#x000f3;g-Garcia et al 2007</a>].</p><p>Several transgenic mouse models of <i>COMP</i> pathogenic variants have been developed to study disease mechanisms in vivo [<a class="bk_pop" href="#edm-ad.REF.schmitz.2008.67">Schmitz et al 2008</a>, <a class="bk_pop" href="#edm-ad.REF.posey.2009.1555">Posey et al 2009</a>, <a class="bk_pop" href="#edm-ad.REF.suleman.2012.218">Suleman et al 2012</a>]. Although the majority of these models have the same pseudoachondroplasia-causing <i>COMP</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (i.e., Asp469del) they nonetheless provide some insight into the disease mechanisms of MED caused by similar <i>COMP</i> pathogenic variants. For example, mutated COMP is retained in the ER of chondrocytes, causing reduced chondrocyte proliferation and increased/dysregulated cell death [<a class="bk_pop" href="#edm-ad.REF.suleman.2012.218">Suleman et al 2012</a>].</p><p>In addition, the generation of a mouse model of MED-pseudoachondroplasia with a p.Thr585Met <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the C-terminal <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> has provided novel insight into disease mechanisms in vivo. Mutated COMP protein is efficiently secreted from the rER of chondrocytes, but still elicits a mild unfolded protein response. This ultimately results in decreased chondrocyte proliferation and increased and spatially dysregulated apoptosis that is possibly mediated by CHOP [<a class="bk_pop" href="#edm-ad.REF.pir_ggarcia.2007.2072">Pir&#x000f3;g-Garcia et al 2007</a>]. More recently, a mild myopathy that originates from an underlying tendon and ligament pathology (which is a direct result of structural abnormalities to the collagen fibril architecture) has been demonstrated in this mouse model [<a class="bk_pop" href="#edm-ad.REF.pir_g.2010.686457">Pir&#x000f3;g &#x00026; Briggs 2010</a>, <a class="bk_pop" href="#edm-ad.REF.pir_g.2010.52">Pir&#x000f3;g et al 2010</a>].</p></div><div id="edm-ad.MATN3"><h4><i>MATN3</i></h4><p><b>Gene structure.</b> The coding sequence of <i>MATN3</i> is organized into eight exons spanning approximately 21 kb. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1123/#edm-ad.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants</b> (see <a class="figpopup" href="/books/NBK1123/table/edm-ad.T.pathogenic_matn3_variants_discu/?report=objectonly" target="object" rid-figpopup="figedmadTpathogenicmatn3variantsdiscu" rid-ob="figobedmadTpathogenicmatn3variantsdiscu">Table 5</a>)</p><ul><li class="half_rhythm"><div>With one exception, all MED-causing variants in <i>MATN3</i> are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants found within <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 2, which encodes the single A <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of matrilin-3. The single exception is a missense variant identified in exon 1 (<a class="figpopup" href="/books/NBK1123/table/edm-ad.T.pathogenic_matn3_variants_discu/?report=objectonly" target="object" rid-figpopup="figedmadTpathogenicmatn3variantsdiscu" rid-ob="figobedmadTpathogenicmatn3variantsdiscu">p.Arg70His</a>) [<a class="bk_pop" href="#edm-ad.REF.maeda.2005.285">Maeda et al 2005</a>]; however, this variant is within five residues of the A domain and may well play a role in its structure and/or function.</div></li><li class="half_rhythm"><div>The vast majority of A-<a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> variants (~70%) affect conserved residues within the six beta-strands that comprise the single beta-sheet of the A domain. Other variants have been described in the alpha-helix regions of the A domain (~30%) [<a class="bk_pop" href="#edm-ad.REF.chapman.2001.393">Chapman et al 2001</a>, <a class="bk_pop" href="#edm-ad.REF.mostert.2003.490">Mostert et al 2003</a>, <a class="bk_pop" href="#edm-ad.REF.jackson.2004.52">Jackson et al 2004</a>, <a class="bk_pop" href="#edm-ad.REF.mabuchi.2004.439">Mabuchi et al 2004</a>, <a class="bk_pop" href="#edm-ad.REF.cotterill.2005.557">Cotterill et al 2005</a>, <a class="bk_pop" href="#edm-ad.REF.itoh.2006.1280">Itoh et al 2006</a>, <a class="bk_pop" href="#edm-ad.REF.fresquet.2008.330">Fresquet et al 2008</a>, <a class="bk_pop" href="#edm-ad.REF.kim.2011.2669">Kim et al 2011</a>, <a class="bk_pop" href="#edm-ad.REF.jackson.2012.144">Jackson et al 2012</a>].</div></li><li class="half_rhythm"><div>Recurrent pathogenic variants have been observed in individuals with <i>MATN3-</i>related MED in several populations:</div><ul><li class="half_rhythm"><div>European-based studies have identified p.Arg121Trp in 12/33 and p.Thr120Met in 5/33 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals (total = 52%) [<a class="bk_pop" href="#edm-ad.REF.chapman.2001.393">Chapman et al 2001</a>; <a class="bk_pop" href="#edm-ad.REF.mostert.2003.490">Mostert et al 2003</a>; <a class="bk_pop" href="#edm-ad.REF.jackson.2004.52">Jackson et al 2004</a>; <a class="bk_pop" href="#edm-ad.REF.cotterill.2005.557">Cotterill et al 2005</a>; <a class="bk_pop" href="#edm-ad.REF.fresquet.2007.34634">Fresquet et al 2007</a>; <a class="bk_pop" href="#edm-ad.REF.jackson.2012.144">Jackson et al 2012</a>; Author, unpublished data].</div></li><li class="half_rhythm"><div>In a Japanese population, p.Arg121Trp was identified in 3/9 and p.Thr120Met in 3/9 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals (total = 66%) [<a class="bk_pop" href="#edm-ad.REF.mabuchi.2004.439">Mabuchi et al 2004</a>, <a class="bk_pop" href="#edm-ad.REF.itoh.2006.1280">Itoh et al 2006</a>].</div></li><li class="half_rhythm"><div>In a Korean study, p.Arg121Trp was identified in 20/30 and p.Thr120Met was identified in 4/30 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals (total = 80%) [<a class="bk_pop" href="#edm-ad.REF.kim.2011.2669">Kim et al 2011</a>].</div></li></ul></li><li class="half_rhythm"><div>While the majority of pathogenic variants lie within the single beta-sheet of the A <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, several variants have been identified in the &#x003b1; helices; namely, p. Leu146Arg, p.Ala173Asp, p.Arg209Pro, p.Lys231Asn and p.Val220Ala [<a class="bk_pop" href="#edm-ad.REF.mabuchi.2004.439">Mabuchi et al 2004</a>, <a class="bk_pop" href="#edm-ad.REF.fresquet.2008.330">Fresquet et al 2008</a>, <a class="bk_pop" href="#edm-ad.REF.kim.2011.2669">Kim et al 2011</a>, <a class="bk_pop" href="#edm-ad.REF.jackson.2012.144">Jackson et al 2012</a>], suggesting that they may have a more widespread distribution than originally thought [<a class="bk_pop" href="#edm-ad.REF.jackson.2004.52">Jackson et al 2004</a>].</div></li><li class="half_rhythm"><div>Several <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> deletions and <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>/insertions have been identified, including p.Asp171_Glu176del [<a class="bk_pop" href="#edm-ad.REF.jackson.2012.144">Jackson et al 2012</a>].</div></li></ul><div id="edm-ad.T.pathogenic_matn3_variants_discu" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p>Pathogenic <i>MATN3</i> Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1123/table/edm-ad.T.pathogenic_matn3_variants_discu/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__edm-ad.T.pathogenic_matn3_variants_discu_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_edm-ad.T.pathogenic_matn3_variants_discu_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_edm-ad.T.pathogenic_matn3_variants_discu_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_edm-ad.T.pathogenic_matn3_variants_discu_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_edm-ad.T.pathogenic_matn3_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.209G&#x0003e;A</td><td headers="hd_h_edm-ad.T.pathogenic_matn3_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg70His</td><td headers="hd_h_edm-ad.T.pathogenic_matn3_variants_discu_1_1_1_3" rowspan="15" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/111119013" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_002381<wbr style="display:inline-block"></wbr>​.4</a><br /><a href="/protein/11321565" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_002372<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_edm-ad.T.pathogenic_matn3_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.359C&#x0003e;T</td><td headers="hd_h_edm-ad.T.pathogenic_matn3_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr120Met</td></tr><tr><td headers="hd_h_edm-ad.T.pathogenic_matn3_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.361C&#x0003e;T</td><td headers="hd_h_edm-ad.T.pathogenic_matn3_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg121Trp</td></tr><tr><td headers="hd_h_edm-ad.T.pathogenic_matn3_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.400G&#x0003e;A</td><td headers="hd_h_edm-ad.T.pathogenic_matn3_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu134Lys</td></tr><tr><td headers="hd_h_edm-ad.T.pathogenic_matn3_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">c.437T&#x0003e;G</td><td headers="hd_h_edm-ad.T.pathogenic_matn3_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">p.Leu146Arg</td></tr><tr><td headers="hd_h_edm-ad.T.pathogenic_matn3_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">c.513_530del</td><td headers="hd_h_edm-ad.T.pathogenic_matn3_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">p.Asp171_Glu176del</td></tr><tr><td headers="hd_h_edm-ad.T.pathogenic_matn3_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">c.518C&#x0003e;A</td><td headers="hd_h_edm-ad.T.pathogenic_matn3_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">p.Ala173Asp</td></tr><tr><td headers="hd_h_edm-ad.T.pathogenic_matn3_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.575T&#x0003e;A</td><td headers="hd_h_edm-ad.T.pathogenic_matn3_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ile192Asn</td></tr><tr><td headers="hd_h_edm-ad.T.pathogenic_matn3_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.581T&#x0003e;A</td><td headers="hd_h_edm-ad.T.pathogenic_matn3_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val194Asp</td></tr><tr><td headers="hd_h_edm-ad.T.pathogenic_matn3_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.584C&#x0003e;A</td><td headers="hd_h_edm-ad.T.pathogenic_matn3_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr195Lys</td></tr><tr><td headers="hd_h_edm-ad.T.pathogenic_matn3_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">c.626G&#x0003e;C</td><td headers="hd_h_edm-ad.T.pathogenic_matn3_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">p.Arg209Pro</td></tr><tr><td headers="hd_h_edm-ad.T.pathogenic_matn3_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.652T&#x0003e;A</td><td headers="hd_h_edm-ad.T.pathogenic_matn3_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr218Asn</td></tr><tr><td headers="hd_h_edm-ad.T.pathogenic_matn3_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.656C&#x0003e;A</td><td headers="hd_h_edm-ad.T.pathogenic_matn3_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala219Asp</td></tr><tr><td headers="hd_h_edm-ad.T.pathogenic_matn3_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.659T&#x0003e;C</td><td headers="hd_h_edm-ad.T.pathogenic_matn3_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val220Ala</td></tr><tr><td headers="hd_h_edm-ad.T.pathogenic_matn3_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.693G&#x0003e;C</td><td headers="hd_h_edm-ad.T.pathogenic_matn3_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Lys231Asn</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Matrilin-3, a protein of 486 amino acids, is the third member of a family of oligomeric multidomain ECM proteins comprising matrilin-1, -2, -3, and -4 [<a class="bk_pop" href="#edm-ad.REF.wagener.2005.3323">Wagener et al 2005</a>]. The <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> structure of the matrilin family of proteins is similar; each consists of:</p><ul><li class="half_rhythm"><div>One or two vWFA domains</div></li><li class="half_rhythm"><div>A varying number of EGF-like repeats</div></li><li class="half_rhythm"><div>A coiled-coil <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, which facilitates oligomerization</div></li></ul><p>Matrilins have been found in collagen-dependent and collagen-independent filament networks within the tissues in which they are expressed and may perform analogous functions in these different tissues. Matrilin-3 has been shown to interact with COMP and other cartilage collagens through the A <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> [<a class="bk_pop" href="#edm-ad.REF.mann.2004.25294">Mann et al 2004</a>, <a class="bk_pop" href="#edm-ad.REF.fresquet.2007.34634">Fresquet et al 2007</a>, <a class="bk_pop" href="#edm-ad.REF.fresquet.2008.330">Fresquet et al 2008</a>, <a class="bk_pop" href="#edm-ad.REF.fresquet.2010.34048">Fresquet et al 2010</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>MATN3</i> pathogenic variants appear to delay the folding of the A <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, which elicits an unfolded protein response and results in the retention of mutated matrilin-3 in the rER both in vitro [<a class="bk_pop" href="#edm-ad.REF.cotterill.2005.557">Cotterill et al 2005</a>, <a class="bk_pop" href="#edm-ad.REF.otten.2005.774">Otten et al 2005</a>] and in vivo [<a class="bk_pop" href="#edm-ad.REF.leighton.2007.1728">Leighton et al 2007</a>, <a class="bk_pop" href="#edm-ad.REF.nundlall.2010.835">Nundlall et al 2010</a>].</p><p>An MED mouse model harboring the p.Val194Asp <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has demonstrated that the expression of this pathogenic variant causes ER stress and an unfolded protein response. Ultimately this results in a reduction in chondrocyte proliferation and dysregulated apoptosis [<a class="bk_pop" href="#edm-ad.REF.leighton.2007.1728">Leighton et al 2007</a>, <a class="bk_pop" href="#edm-ad.REF.nundlall.2010.835">Nundlall et al 2010</a>]. Interestingly, retained abnormal matrilin-3 forms non-native disulphide-bonded aggregates.</p></div></div></div><div id="edm-ad.References"><h2 id="_edm-ad_References_">References</h2><div id="edm-ad.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.annunen.1999.409">Annunen S, Paassilta P, Lohiniva J, Perala M, Pihlajamaa T, Karppinen J, Tervonen O, Kroger H, Lahde S, Vanharanta H, Ryhanen L, Goring HH, Ott J, Prockop DJ, Ala-Kokko L. An allele of COL9A2 associated with intervertebral disc disease. <span><span class="ref-journal">Science. </span>1999;<span class="ref-vol">285</span>:409–12.</span> [<a href="/pubmed/10411504" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10411504</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.blumbach.2008.306">Blumbach K, Niehoff A, Paulsson M, Zaucke F. Ablation of collagen IX and COMP disrupts epiphyseal cartilage architecture. <span><span class="ref-journal">Matrix Biol. </span>2008;<span class="ref-vol">27</span>:306–18.</span> [<a href="/pubmed/18191556" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18191556</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.bonafe.2015.2869">Bonafe L, Cormier-Daire V, Hall C, Lachman R, Mortier G, Mundlos S, Nishimura G, Sangiorgi L, Savarirayan R, Sillence D, Spranger J, Superti-Furga A, Warman M, Unger S. Nosology and classification of genetic skeletal disorders: 2015 revision. <span><span class="ref-journal">Am J Med Genet A. </span>2015;<span class="ref-vol">167A</span>:2869–92.</span> [<a href="/pubmed/26394607" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26394607</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.b_nnemann.2000.1212">B&#x000f6;nnemann CG, Cox GF, Shapiro F, Wu JJ, Feener CA, Thompson TG, Anthony DC, Eyre DR, Darras BT, Kunkel LM. A mutation in the alpha 3 chain of type IX collagen causes autosomal dominant multiple epiphyseal dysplasia with mild myopathy. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2000;<span class="ref-vol">97</span>:1212–7.</span> [<a href="/pmc/articles/PMC15572/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC15572</span></a>] [<a href="/pubmed/10655510" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10655510</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.borochowitz.2004.366">Borochowitz ZU, Scheffer D, Adir V, Dagoneau N, Munnich A, Cormier-Daire V. Spondylo-epi-metaphyseal dysplasia (SEMD) matrilin 3 type: homozygote matrilin 3 mutation in a novel form of SEMD. <span><span class="ref-journal">J Med Genet. </span>2004;<span class="ref-vol">41</span>:366–72.</span> [<a href="/pmc/articles/PMC1735768/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735768</span></a>] [<a href="/pubmed/15121775" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15121775</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.briggs.2015.1137">Briggs MD, Bell PA, Wright MJ, Pirog KA. New therapeutic targets in rare genetic skeletal diseases. <span><span class="ref-journal">Expert Opin Orphan Drugs. </span>2015;<span class="ref-vol">3</span>:1137–54.</span> [<a href="/pmc/articles/PMC4643203/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4643203</span></a>] [<a href="/pubmed/26635999" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26635999</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.briggs.2014.1278">Briggs MD, Brock J, Ramsden SC, Bell PA. Genotype to phenotype correlations in cartilage oligomeric matrix protein associated chondrodysplasias. <span><span class="ref-journal">Eur J Hum Genet. </span>2014;<span class="ref-vol">22</span>:1278–82.</span> [<a href="/pmc/articles/PMC4051597/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4051597</span></a>] [<a href="/pubmed/24595329" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24595329</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.briggs.2002.465">Briggs MD, Chapman KL. Pseudoachondroplasia and multiple epiphyseal dysplasia: mutation review, molecular interactions, and genotype to phenotype correlations. <span><span class="ref-journal">Hum Mutat. </span>2002;<span class="ref-vol">19</span>:465–78.</span> [<a href="/pubmed/11968079" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11968079</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.budde.2005.10465">Budde B, Blumbach K, Yl&#x000f6;stalo J, Zaucke F, Ehlen HW, Wagener R, Ala-Kokko L, Paulsson M, Bruckner P, Gr&#x000e4;ssel S. Altered integration of matrilin-3 into cartilage extracellular matrix in the absence of collagen IX. <span><span class="ref-journal">Mol Cell Biol. </span>2005;<span class="ref-vol">25</span>:10465–78.</span> [<a href="/pmc/articles/PMC1291247/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1291247</span></a>] [<a href="/pubmed/16287859" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16287859</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.chapman.2001.393">Chapman KL, Mortier GR, Chapman K, Loughlin J, Grant ME, Briggs MD. Mutations in the region encoding the von Willebrand factor A domain of matrilin-3 are associated with multiple epiphyseal dysplasia. <span><span class="ref-journal">Nat Genet. </span>2001;<span class="ref-vol">28</span>:393–6.</span> [<a href="/pubmed/11479597" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11479597</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.chen.2000.26538">Chen H, Deere M, Hecht JT, Lawler J. Cartilage oligomeric matrix protein is a calcium-binding protein, and a mutation in its type 3 repeats causes conformational changes. <span><span class="ref-journal">J Biol Chem. </span>2000;<span class="ref-vol">275</span>:26538–44.</span> [<a href="/pubmed/10852928" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10852928</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.cilliers.1990.386">Cilliers HJ, Beighton P. Beukes familial hip dysplasia: an autosomal dominant entity. <span><span class="ref-journal">Am J Med Genet. </span>1990;<span class="ref-vol">36</span>:386–90.</span> [<a href="/pubmed/2389793" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2389793</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.cotterill.2005.557">Cotterill SL, Jackson GC, Leighton MP, Wagener R, Makitie O, Cole WG, Briggs MD. Multiple epiphyseal dysplasia mutations in MATN3 cause misfolding of the A-domain and prevent secretion of mutant matrilin-3. <span><span class="ref-journal">Hum Mutat. </span>2005;<span class="ref-vol">26</span>:557–65.</span> [<a href="/pmc/articles/PMC2726956/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2726956</span></a>] [<a href="/pubmed/16287128" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16287128</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.di_cesare.2002.461">Di Cesare PE, Chen FS, Moergelin M, Carlson CS, Leslie MP, Perris R, Fang C. Matrix-matrix interaction of cartilage oligomeric matrix protein and fibronectin. <span><span class="ref-journal">Matrix Biol. </span>2002;<span class="ref-vol">21</span>:461–70.</span> [<a href="/pubmed/12225811" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12225811</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.elsbach.1959.514">Elsbach L. Bilateral hereditary micro-epiphysial dysplasia of the hips. <span><span class="ref-journal">J Bone Joint Surg Br. </span>1959;<span class="ref-vol">41-B</span>:514–23.</span> [<a href="/pubmed/13849708" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 13849708</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.fresquet.2008.330">Fresquet M, Jackson GC, Loughlin J, Briggs MD. Novel mutations in exon 2 of MATN3 affect residues within the alpha-helices of the A-domain and can result in the intracellular retention of mutant matrilin-3. <span><span class="ref-journal">Hum Mutat. </span>2008;<span class="ref-vol">29</span>:330.</span> [<a href="/pubmed/18205203" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18205203</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.fresquet.2010.34048">Fresquet M, Jowitt TA, Stephen LA, Yl&#x000f6;stalo J, Briggs MD. Structural and functional investigations of Matrilin-1 A-domains reveal insights into their role in cartilage ECM assembly. <span><span class="ref-journal">J Biol Chem. </span>2010;<span class="ref-vol">285</span>:34048–61.</span> [<a href="/pmc/articles/PMC2962504/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2962504</span></a>] [<a href="/pubmed/20729554" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20729554</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.fresquet.2007.34634">Fresquet M, Jowitt TA, Yl&#x000f6;stalo J, Coffey P, Meadows RS, Ala-Kokko L, Thornton DJ, Briggs MD. Structural and functional characterization of recombinant matrilin-3 A-domain and implications for human genetic bone diseases. <span><span class="ref-journal">J Biol Chem. </span>2007;<span class="ref-vol">282</span>:34634–43.</span> [<a href="/pmc/articles/PMC2673055/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2673055</span></a>] [<a href="/pubmed/17881354" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17881354</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.gu.2012.656084">Gu J, Rong J, Guan F, Jiang L, Tao S, Guan G, Tao T. MATN3 gene polymorphism is associated with osteoarthritis in Chinese Han population: a community-based case-control study. <span><span class="ref-journal">ScientificWorldJournal. </span>2012;<span class="ref-vol">2012</span>:656084.</span> [<a href="/pmc/articles/PMC3432353/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3432353</span></a>] [<a href="/pubmed/22973175" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22973175</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.holden.2001.6046">Holden P, Meadows RS, Chapman KL, Grant ME, Kadler KE, Briggs MD. Cartilage oligomeric matrix protein interacts with type IX collagen, and disruptions to these interactions identify a pathogenetic mechanism in a bone dysplasia family. <span><span class="ref-journal">J Biol Chem. </span>2001;<span class="ref-vol">276</span>:6046–55.</span> [<a href="/pubmed/11087755" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11087755</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.itoh.2006.1280">Itoh T, Shirahama S, Nakashima E, Maeda K, Haga N, Kitoh H, Kosaki R, Ohashi H, Nishimura G, Ikegawa S. Comprehensive screening of multiple epiphyseal dysplasia mutations in Japanese population. <span><span class="ref-journal">Am J Med Genet A. </span>2006;<span class="ref-vol">140</span>:1280–4.</span> [<a href="/pubmed/16691584" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16691584</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.jackson.2004.52">Jackson GC, Barker FS, Jakkula E, Czarny-Ratajczak M, Makitie O, Cole WG, Wright MJ, Smithson SF, Suri M, Rogala P, Mortier GR, Baldock C, Wallace A, Elles R, Ala-Kokko L, Briggs MD. Missense mutations in the beta strands of the single A-domain of matrilin-3 result in multiple epiphyseal dysplasia. <span><span class="ref-journal">J Med Genet. </span>2004;<span class="ref-vol">41</span>:52–9.</span> [<a href="/pmc/articles/PMC1757268/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1757268</span></a>] [<a href="/pubmed/14729835" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14729835</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.jackson.2012.144">Jackson GC, Mittaz-Crettol L, Taylor JA, Mortier GR, Spranger J, Zabel B, LeMerrer M, Cormier-Daire V, Hall CM, Offiah A, Wright MJ, Savarirayan R, Nishimura G, Ramsden SC, Elles R, Bonafe L, Superti-Furga A, Unger S, Zankl A, Briggs MD. Pseudoachondroplasia and multiple epiphyseal dysplasia: a 7-year comprehensive analysis of the known disease genes identify novel and recurrent mutations and provides an accurate assessment of their relative contribution. <span><span class="ref-journal">Hum Mutat. </span>2012;<span class="ref-vol">33</span>:144–57.</span> [<a href="/pmc/articles/PMC3272220/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3272220</span></a>] [<a href="/pubmed/21922596" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21922596</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.jakkula.2003.942">Jakkula E, Lohiniva J, Capone A, Bonafe L, Marti M, Schuster V, Giedion A, Eich G, Boltshauser E, Ala-Kokko L, Superti-Furga A. A recurrent R718W mutation in COMP results in multiple epiphyseal dysplasia with mild myopathy: clinical and pathogenetic overlap with collagen IX mutations. <span><span class="ref-journal">J Med Genet. </span>2003;<span class="ref-vol">40</span>:942–8.</span> [<a href="/pmc/articles/PMC1735347/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735347</span></a>] [<a href="/pubmed/14684695" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14684695</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.jakkula.2005.292">Jakkula E, Makitie O, Czarny-Ratajczak M, Jackson GC, Damignani R, Susic M, Briggs MD, Cole WG, Ala-Kokko L. Mutations in the known genes are not the major cause of MED; distinctive phenotypic entities among patients with no identified mutations. <span><span class="ref-journal">Eur J Hum Genet. </span>2005;<span class="ref-vol">13</span>:292–301.</span> [<a href="/pubmed/15523498" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15523498</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.kannu.2011.1785">Kannu P, Irving M, Aftimos S, Savarirayan R. Two novel COL2A1 mutations associated with a Legg-Calv&#x000e9;-Perthes disease-like presentation. <span><span class="ref-journal">Clin Orthop Relat Res. </span>2011;<span class="ref-vol">469</span>:1785–90.</span> [<a href="/pmc/articles/PMC3094608/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3094608</span></a>] [<a href="/pubmed/21442341" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21442341</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.kennedy.2005a.593">Kennedy J, Jackson G, Barker FS, Nundlall S, Bella J, Wright MJ, Mortier GR, Neas K, Thompson E, Elles R, Briggs MD. Novel and recurrent mutations in the C-terminal domain of COMP cluster in two distinct regions and result in a spectrum of phenotypes within the pseudoachondroplasia -- multiple epiphyseal dysplasia disease group. <span><span class="ref-journal">Hum Mutat. </span>2005a;<span class="ref-vol">25</span>:593–4.</span> [<a href="/pubmed/15880723" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15880723</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.kennedy.2005b.547">Kennedy J, Jackson G, Ramsden S, Taylor J, Newman W, Wright MJ, Donnai D, Elles R, Briggs MD. COMP mutation screening as an aid for the clinical diagnosis and counselling of patients with a suspected diagnosis of pseudoachondroplasia or multiple epiphyseal dysplasia. <span><span class="ref-journal">Eur J Hum Genet. </span>2005b;<span class="ref-vol">13</span>:547–55.</span> [<a href="/pmc/articles/PMC2673054/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2673054</span></a>] [<a href="/pubmed/15756302" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15756302</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.kim.2011.2669">Kim OH, Park H, Seong MW, Cho TJ, Nishimura G, Superti-Furga A, Unger S, Ikegawa S, Choi IH, Song HR, Kim HW, Yoo WJ, Shim JS, Chung CY, Oh CW, Jeong C, Song KS, Seo SG, Cho SI, Yeo IK, Kim SY, Park S, Park SS. Revisit of multiple epiphyseal dysplasia: ethnic difference in genotypes and comparison of radiographic features linked to the COMP and MATN3 genes. <span><span class="ref-journal">Am J Med Genet A. </span>2011;<span class="ref-vol">155A</span>:2669–80.</span> [<a href="/pubmed/21965141" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21965141</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.kleerekoper.2002.10581">Kleerekoper Q, Hecht JT, Putkey JA. Disease-causing mutations in cartilage oligomeric matrix protein cause an unstructured Ca2+ binding domain. <span><span class="ref-journal">J Biol Chem. </span>2002;<span class="ref-vol">277</span>:10581–9.</span> [<a href="/pubmed/11782471" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11782471</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.leighton.2007.1728">Leighton MP, Nundlall S, Starborg T, Meadows RS, Suleman F, Knowles L, Wagener R, Thornton DJ, Kadler KE, Boot-Handford RP, Briggs MD. Decreased chondrocyte proliferation and dysregulated apoptosis in the cartilage growth plate are key features of a murine model of epiphyseal dysplasia caused by a matn3 mutation. <span><span class="ref-journal">Hum Mol Genet. </span>2007;<span class="ref-vol">16</span>:1728–41.</span> [<a href="/pmc/articles/PMC2674230/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2674230</span></a>] [<a href="/pubmed/17517694" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17517694</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.liu.2005.2294">Liu YF, Chen WM, Lin YF, Yang RC, Lin MW, Li LH, Chang YH, Jou YS, Lin PY, Su JS, Huang SF, Hsiao KJ, Fann CS, Hwang HW, Chen YT, Tsai SF. Type II collagen gene variants and inherited osteonecrosis of the femoral head. <span><span class="ref-journal">N Engl J Med. </span>2005;<span class="ref-vol">352</span>:2294–301.</span> [<a href="/pubmed/15930420" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15930420</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.mabuchi.2004.439">Mabuchi A, Haga N, Maeda K, Nakashima E, Manabe N, Hiraoka H, Kitoh H, Kosaki R, Nishimura G, Ohashi H, Ikegawa S. Novel and recurrent mutations clustered in the von Willebrand factor A domain of MATN3 in multiple epiphyseal dysplasia. <span><span class="ref-journal">Hum Mutat. </span>2004;<span class="ref-vol">24</span>:439–40.</span> [<a href="/pubmed/15459972" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15459972</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.maddox.2000.11412">Maddox BK, Mokashi A, Keene DR, Bachinger HP. A cartilage oligomeric matrix protein mutation associated with pseudoachondroplasia changes the structural and functional properties of the type 3 domain. <span><span class="ref-journal">J Biol Chem. </span>2000;<span class="ref-vol">275</span>:11412–7.</span> [<a href="/pubmed/10753957" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10753957</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.maeda.2005.285">Maeda K, Nakashima E, Horikoshi T, Mabuchi A, Ikegawa S. Mutation in the von Willebrand factor-A domain is not a prerequisite for the MATN3 mutation in multiple epiphyseal dysplasia. <span><span class="ref-journal">Am J Med Genet A. </span>2005;<span class="ref-vol">136</span>:285–6.</span> [<a href="/pubmed/15948199" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15948199</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.m_kitie.2004.278">M&#x000e4;kitie O, Mortier GR, Czarny-Ratajczak M, Wright MJ, Suri M, Rogala P, Freund M, Jackson GC, Jakkula E, Ala-Kokko L, Briggs MD, Cole WG. Clinical and radiographic findings in multiple epiphyseal dysplasia caused by MATN3 mutations: description of 12 patients. <span><span class="ref-journal">Am J Med Genet A. </span>2004;<span class="ref-vol">125A</span>:278–84.</span> [<a href="/pubmed/14994237" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14994237</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.mann.2004.25294">Mann HH, Ozbek S, Engel J, Paulsson M, Wagener R. Interactions between the cartilage oligomeric matrix protein and matrilins. Implications for matrix assembly and the pathogenesis of chondrodysplasias. <span><span class="ref-journal">J Biol Chem. </span>2004;<span class="ref-vol">279</span>:25294–8.</span> [<a href="/pubmed/15075323" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15075323</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.min.2006.1060">Min JL, Meulenbelt I, Riyazi N, Kloppenburg M, Houwing-Duistermaat JJ, Seymour AB, van Duijn CM, Slagboom PE. Association of matrilin-3 polymorphisms with spinal disc degeneration and osteoarthritis of the first carpometacarpal joint of the hand. <span><span class="ref-journal">Ann Rheum Dis. </span>2006;<span class="ref-vol">65</span>:1060–6.</span> [<a href="/pmc/articles/PMC1798238/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1798238</span></a>] [<a href="/pubmed/16396979" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16396979</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.miyamoto.2007.625">Miyamoto Y, Matsuda T, Kitoh H, Haga N, Ohashi H, Nishimura G, Ikegawa S. A recurrent mutation in type II collagen gene causes Legg-Calv&#x000e9;-Perthes disease in a Japanese family. <span><span class="ref-journal">Hum Genet. </span>2007;<span class="ref-vol">121</span>:625–9.</span> [<a href="/pubmed/17394019" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17394019</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.mortier.2001.606">Mortier GR, Chapman K, Leroy JL, Briggs MD. Clinical and radiographic features of multiple epiphyseal dysplasia not linked to the COMP or type IX collagen genes. <span><span class="ref-journal">Eur J Hum Genet. </span>2001;<span class="ref-vol">9</span>:606–12.</span> [<a href="/pubmed/11528506" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11528506</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.mostert.2003.490">Mostert AK, Dijkstra PF, Jansen BR, van Horn JR, de Graaf B, Heutink P, Lindhout D. Familial multiple epiphyseal dysplasia due to a matrilin-3 mutation: further delineation of the phenotype including 40 years follow-up. <span><span class="ref-journal">Am J Med Genet. </span>2003;<span class="ref-vol">120A</span>:490–7.</span> [<a href="/pubmed/12884427" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12884427</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.nakashima.2005.181">Nakashima E, Kitoh H, Maeda K, Haga N, Kosaki R, Mabuchi A, Nishimura G, Ohashi H, Ikegawa S. Novel COL9A3 mutation in a family with multiple epiphyseal dysplasia. <span><span class="ref-journal">Am J Med Genet A. </span>2005;<span class="ref-vol">132A</span>:181–4.</span> [<a href="/pubmed/15551337" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15551337</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.nundlall.2010.835">Nundlall S, Rajpar MH, Bell PA, Clowes C, Zeeff LA, Gardner B, Thornton DJ, Boot-Handford RP, Briggs MD. An unfolded protein response is the initial cellular response to the expression of mutant matrilin-3 in a mouse model of multiple epiphyseal dysplasia. <span><span class="ref-journal">Cell Stress Chaperones. </span>2010;<span class="ref-vol">15</span>:835–49.</span> [<a href="/pmc/articles/PMC3024081/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3024081</span></a>] [<a href="/pubmed/20428984" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20428984</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.odman.1959.97">Odman P. Hereditary enchondral dysostosis; twelve cases in three generations mainly with peripheral location. <span><span class="ref-journal">Acta Radiol. </span>1959;<span class="ref-vol">52</span>:97–113.</span> [<a href="/pubmed/14428296" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14428296</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.otten.2010.254">Otten C, Hansen U, Talke A, Wagener R, Paulsson M, Zaucke F. A matrilin-3 mutation associated with osteoarthritis does not affect collagen affinity but promotes the formation of wider cartilage collagen fibrils. <span><span class="ref-journal">Hum Mutat. </span>2010;<span class="ref-vol">31</span>:254–63.</span> [<a href="/pubmed/20077500" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20077500</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.otten.2005.774">Otten C, Wagener R, Paulsson M, Zaucke F. Matrilin-3 mutations that cause chondrodysplasias interfere with protein trafficking while a mutation associated with hand osteoarthritis does not. <span><span class="ref-journal">J Med Genet. </span>2005;<span class="ref-vol">42</span>:774–9.</span> [<a href="/pmc/articles/PMC1735938/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735938</span></a>] [<a href="/pubmed/16199550" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16199550</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.paassilta.2001.1843">Paassilta P, Lohiniva J, Goring HH, Perala M, Raina SS, Karppinen J, Hakala M, Palm T, Kroger H, Kaitila I, Vanharanta H, Ott J, Ala-Kokko L. Identification of a novel common genetic risk factor for lumbar disk disease. <span><span class="ref-journal">JAMA. </span>2001;<span class="ref-vol">285</span>:1843–9.</span> [<a href="/pubmed/11308397" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11308397</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.paassilta.1999.22469">Paassilta P, Pihlajamaa T, Annunen S, Brewton RG, Wood BM, Johnson CC, Liu J, Gong Y, Warman ML, Prockop DJ, Mayne R, Ala-Kokko L. Complete sequence of the 23-kilobase human COL9A3 gene. Detection of Gly-X-Y triplet deletions that represent neutral variants. <span><span class="ref-journal">J Biol Chem. </span>1999;<span class="ref-vol">274</span>:22469–75.</span> [<a href="/pubmed/10428822" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10428822</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.pihlajamaa.1998.237">Pihlajamaa T, Vuoristo MM, Annunen S, Perala M, Prockop DJ, Ala-Kokko L. Human COL9A1 and COL9A2 genes. Two genes of 90 and 15 kb code for similar polypeptides of the same collagen molecule. <span><span class="ref-journal">Matrix Biol. </span>1998;<span class="ref-vol">17</span>:237–41.</span> [<a href="/pubmed/9707347" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9707347</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.pir_g.2010.686457">Pir&#x000f3;g KA, Briggs MD. Skeletal dysplasias associated with mild myopathy-a clinical and molecular review. <span><span class="ref-journal">J Biomed Biotechnol. </span>2010;<span class="ref-vol">2010</span>:686457.</span> [<a href="/pmc/articles/PMC2875749/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2875749</span></a>] [<a href="/pubmed/20508815" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20508815</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.pir_g.2010.52">Pir&#x000f3;g KA, Jaka O, Katakura Y, Meadows RS, Kadler KE, Boot-Handford RP, Briggs MD. A mouse model offers novel insights into the myopathy and tendinopathy often associated with pseudoachondroplasia and multiple epiphyseal dysplasia. <span><span class="ref-journal">Hum Mol Genet. </span>2010;<span class="ref-vol">19</span>:52–64.</span> [<a href="/pmc/articles/PMC2792148/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2792148</span></a>] [<a href="/pubmed/19808781" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19808781</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.pir_ggarcia.2007.2072">Pir&#x000f3;g-Garcia KA, Meadows RS, Knowles L, Heineg&#x000e5;rd D, Thornton DJ, Kadler KE, Boot-Handford RP, Briggs MD. Reduced cell proliferation and increased apoptosis are significant pathological mechanisms in a murine model of mild pseudoachondroplasia resulting from a mutation in the C-terminal domain of COMP. <span><span class="ref-journal">Hum Mol Genet. </span>2007;<span class="ref-vol">16</span>:2072–88.</span> [<a href="/pmc/articles/PMC2674228/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2674228</span></a>] [<a href="/pubmed/17588960" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17588960</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.posey.2009.1555">Posey KL, Veerisetty AC, Liu P, Wang HR, Poindexter BJ, Bick R, Alcorn JL, Hecht JT. An inducible cartilage oligomeric matrix protein mouse model recapitulates human pseudoachondroplasia phenotype. <span><span class="ref-journal">Am J Pathol. </span>2009;<span class="ref-vol">175</span>:1555–63.</span> [<a href="/pmc/articles/PMC2751552/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2751552</span></a>] [<a href="/pubmed/19762713" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19762713</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.pullig.2007.279">Pullig O, Tagariello A, Schweizer A, Swoboda B, Schaller P, Winterpacht A. MATN3 (matrilin-3) sequence variation (pT303M) is a risk factor for osteoarthritis of the CMC1 joint of the hand, but not for knee osteoarthritis. <span><span class="ref-journal">Ann Rheum Dis. </span>2007;<span class="ref-vol">66</span>:279–80.</span> [<a href="/pmc/articles/PMC1798488/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1798488</span></a>] [<a href="/pubmed/17242023" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17242023</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.rosenberg.1998.20397">Rosenberg K, Olsson H, Morgelin M, Heinegard D. Cartilage oligomeric matrix protein shows high affinity zinc-dependent interaction with triple helical collagen. <span><span class="ref-journal">J Biol Chem. </span>1998;<span class="ref-vol">273</span>:20397–403.</span> [<a href="/pubmed/9685393" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9685393</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.schmitz.2006.32587">Schmitz M, Becker A, Schmitz A, Weirich C, Paulsson M, Zaucke F, Dinser R. Disruption of extracellular matrix structure may cause pseudoachondroplasia phenotypes in the absence of impaired cartilage oligomeric matrix protein secretion. <span><span class="ref-journal">J Biol Chem. </span>2006;<span class="ref-vol">281</span>:32587–95.</span> [<a href="/pubmed/16928687" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16928687</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.schmitz.2008.67">Schmitz M, Niehoff A, Miosge N, Smyth N, Paulsson M, Zaucke F. Transgenic mice expressing D469Delta mutated cartilage oligomeric matrix protein (COMP) show growth plate abnormalities and sternal malformations. <span><span class="ref-journal">Matrix Biol. </span>2008;<span class="ref-vol">27</span>:67–85.</span> [<a href="/pubmed/17889519" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17889519</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.spitznagel.2004.479">Spitznagel L, Nitsche DP, Paulsson M, Maurer P, Zaucke F. Characterization of a pseudoachondroplasia-associated mutation (His587--&#x0003e;Arg) in the C-terminal, collagen-binding domain of cartilage oligomeric matrix protein (COMP). <span><span class="ref-journal">Biochem J. </span>2004;<span class="ref-vol">377</span>:479–87.</span> [<a href="/pmc/articles/PMC1223886/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1223886</span></a>] [<a href="/pubmed/14580238" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14580238</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.stef_nsson.2003.1448">Stef&#x000e1;nsson SE, J&#x000f3;nsson H, Ingvarsson T, Manolescu I, J&#x000f3;nsson HH, Olafsd&#x000f3;ttir G, P&#x000e1;lsd&#x000f3;ttir E, Stef&#x000e1;nsd&#x000f3;ttir G, Sveinbj&#x000f6;rnsd&#x000f3;ttir G, Frigge ML, Kong A, Gulcher JR, Stef&#x000e1;nsson K. Genomewide scan for hand osteoarthritis: a novel mutation in matrilin-3. <span><span class="ref-journal">Am J Hum Genet. </span>2003;<span class="ref-vol">72</span>:1448–59.</span> [<a href="/pmc/articles/PMC1180305/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1180305</span></a>] [<a href="/pubmed/12736871" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12736871</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.suleman.2012.218">Suleman F, Gualeni B, Gregson HJ, Leighton MP, Pir&#x000f3;g KA, Edwards S, Holden P, Boot-Handford RP, Briggs MD. A novel form of chondrocyte stress is triggered by a COMP mutation causing pseudoachondroplasia. <span><span class="ref-journal">Hum Mutat. </span>2012;<span class="ref-vol">33</span>:218–31.</span> [<a href="/pmc/articles/PMC3320758/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3320758</span></a>] [<a href="/pubmed/22006726" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22006726</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.thur.2001.6083">Thur J, Rosenberg K, Nitsche DP, Pihlajamaa T, Ala-Kokko L, Heinegard D, Paulsson M, Maurer P. Mutations in cartilage oligomeric matrix protein causing pseudoachondroplasia and multiple epiphyseal dysplasia affect binding of calcium and collagen I, II, and IX. <span><span class="ref-journal">J Biol Chem. </span>2001;<span class="ref-vol">276</span>:6083–92.</span> [<a href="/pubmed/11084047" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11084047</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.unger.2001.244">Unger S, Hecht JT. Pseudoachondroplasia and multiple epiphyseal dysplasia: new etiologic developments. <span><span class="ref-journal">Am J Med Genet. </span>2001;<span class="ref-vol">106</span>:244–50.</span> [<a href="/pubmed/11891674" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11891674</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.unger.2001.10">Unger SL, Briggs MD, Holden P, Zabel B, Ala-Kokko L, Paassilta P, Lohiniva J, Rimoin DL, Lachman RS, Cohn DH. Multiple epiphyseal dysplasia: radiographic abnormalities correlated with genotype. <span><span class="ref-journal">Pediatr Radiol. </span>2001;<span class="ref-vol">31</span>:10–8.</span> [<a href="/pubmed/11200990" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11200990</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.wagener.2005.3323">Wagener R, Ehlen HW, Ko YP, Kobbe B, Mann HH, Sengle G, Paulsson M. The matrilins--adaptor proteins in the extracellular matrix. <span><span class="ref-journal">FEBS Lett. </span>2005;<span class="ref-vol">579</span>:3323–9.</span> [<a href="/pubmed/15943978" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15943978</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.watson.2015.558">Watson CM, Crinnion LA, Gleghorn L, Newman WG, Ramesar R, Beighton P, Wallis GA. Identification of a mutation in the ubiquitin-fold modifier 1-specific peptidase 2 gene, UFSP2, in an extended South African family with Beukes hip dysplasia. <span><span class="ref-journal">S Afr Med J. </span>2015;<span class="ref-vol">105</span>:558–63.</span> [<a href="/pubmed/26428751" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26428751</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.zankl.2007.150">Zankl A, Jackson GC, Crettol LM, Taylor J, Elles R, Mortier GR, Spranger J, Zabel B, Unger S, Merrer ML, Cormier-Daire V, Hall CM, Wright MJ, Bonafe L, Superti-Furga A, Briggs MD. Preselection of cases through expert clinical and radiological review significantly increases mutation detection rate in multiple epiphyseal dysplasia. <span><span class="ref-journal">Eur J Hum Genet. </span>2007;<span class="ref-vol">15</span>:150–4.</span> [<a href="/pmc/articles/PMC2670452/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2670452</span></a>] [<a href="/pubmed/17133256" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17133256</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.zaucke.2009.1067">Zaucke F, Gr&#x000e4;ssel S. Genetic mouse models for the functional analysis of the perifibrillar components collagen IX, COMP and matrilin-3: implications for growth cartilage differentiation and endochondral ossification. <span><span class="ref-journal">Histol Histopathol. </span>2009;<span class="ref-vol">24</span>:1067–79.</span> [<a href="/pubmed/19554514" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19554514</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="edm-ad.REF.zhao.2012.917">Zhao J, Xia W, Nie M, Zheng X, Wang Q, Wang X, Wang W, Ning Z, Huang W, Jiang Y, Li M, Wang O, Xing X, Sun Y, Luo L, He S, Yu W, Lin Q, Pei Y, Zhang F, Han Y, Tong Y, Che Y, Shen R, Hu Y, Zhou X, Chen Q, Xu L. A haplotype of MATN3 is associated with vertebral fracture in Chinese postmenopausal women: Peking Vertebral Fracture (PK-VF) study. <span><span class="ref-journal">Bone. </span>2012;<span class="ref-vol">50</span>:917–24.</span> [<a href="/pmc/articles/PMC6122846/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6122846</span></a>] [<a href="/pubmed/22270056" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22270056</span></a>]</div></li></ul></div></div><div id="edm-ad.Chapter_Notes"><h2 id="_edm-ad_Chapter_Notes_">Chapter Notes</h2><div id="edm-ad.Author_Notes"><h3>Author Notes</h3><p><a href="http://www.esdn.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">European Skeletal Dysplasia Network (ESDN)</a></p></div><div id="edm-ad.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>25 April 2019 (ha) Comprehensive update posted live</div></li><li class="half_rhythm"><div>19 November 2015 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>25 July 2013 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>1 February 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>18 April 2007 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>24 January 2005 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>8 January 2003 (me) Review posted live</div></li><li class="half_rhythm"><div>10 October 2002 (gm) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1123</span><span class="label">PMID: <a href="/pubmed/20301302" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301302</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/men2/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/edm/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1123&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1123/?report=reader">PubReader</a></li><li><a href="/books/NBK1123/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1123" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1123" style="display:none" title="Cite this Page"><div class="bk_tt">Briggs MD, Wright MJ, Mortier GR. Multiple Epiphyseal Dysplasia, Autosomal Dominant. 2003 Jan 8 [Updated 2019 Apr 25]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1123/pdf/Bookshelf_NBK1123.pdf">PDF version of this page</a> (513K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#edm-ad.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#edm-ad.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#edm-ad.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#edm-ad.Genetically_Related_Allelic_Disor" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#edm-ad.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#edm-ad.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#edm-ad.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#edm-ad.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#edm-ad.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#edm-ad.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#edm-ad.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4148[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MATN3</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1299[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">COL9A3</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1297[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">COL9A1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1311[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">COMP</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1298[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">COL9A2</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK1123+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1464918" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1464918" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1464918" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1464918" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31633898" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Schmid Metaphyseal Chondrodysplasia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Schmid Metaphyseal Chondrodysplasia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Richmond CM, Savarirayan R. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/11528506" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Clinical and radiographic features of multiple epiphyseal dysplasia not linked to the COMP or type IX collagen genes.</a><span class="source">[Eur J Hum Genet. 2001]</span><div class="brieflinkpop offscreen_noflow">Clinical and radiographic features of multiple epiphyseal dysplasia not linked to the COMP or type IX collagen genes.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Mortier GR, Chapman K, Leroy JL, Briggs MD. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Eur J Hum Genet. 2001 Aug; 9(8):606-12. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/11565064" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">A mutation in COL9A1 causes multiple epiphyseal dysplasia: further evidence for locus heterogeneity.</a><span class="source">[Am J Hum Genet. 2001]</span><div class="brieflinkpop offscreen_noflow">A mutation in COL9A1 causes multiple epiphyseal dysplasia: further evidence for locus heterogeneity.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Czarny-Ratajczak M, Lohiniva J, Rogala P, Kozlowski K, Perälä M, Carter L, Spector TD, Kolodziej L, Seppänen U, Glazar R, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Hum Genet. 2001 Nov; 69(5):969-80. Epub 2001 Sep 14.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301660" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Pseudoachondroplasia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Pseudoachondroplasia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Briggs MD, Wright MJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24830047" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">TRPV4</i>-Associated Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">TRPV4</i>-Associated Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Schindler A, Sumner C, Hoover-Fong JE. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301302" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301302" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc92b575f66d18aacc3cb0">Multiple Epiphyseal Dysplasia, Autosomal Dominant - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Multiple Epiphyseal Dysplasia, Autosomal Dominant - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T04:21:57-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE884520DFC83B3100000000072C035D&amp;ncbi_session=CE884520DFC92B41_1836SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1123%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1123&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1123/&amp;ncbi_pagename=Multiple Epiphyseal Dysplasia, Autosomal Dominant - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE884520DFC92B41_1836SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>